Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
T.CD8_transitional.APC_like: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 6,230 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TXNL1 levels | PROLV002126 | 57.56 | Protein levels | Lymphocyte | 35 | 2 | 13 | 14 | |
| 2 | CRTAM/VCAM1 ratio | PRORT000775 | 53.05 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 3 | GZMA/GZMH ratio | PRORT001258 | 51.12 | Protein ratios | Lymphocyte | 23 | 2 | 12 | 23 | |
| 4 | RBFOX3 levels | PROLV001708 | 50.90 | Protein levels | Lymphocyte | 0 | 2 | 16 | 35 | |
| 5 | TNFRSF8 levels | PROLV002073 | 50.29 | Protein levels | Lymphocyte | 95 | 2 | 20 | 28 | |
| 6 | FCRL6 levels | PROLV000787 | 49.42 | Protein levels | Lymphocyte | 109 | 2 | 11 | 30 | |
| 7 | Multiple sclerosis | IMMUN000034 | 48.75 | Immunologic | Lymphocyte | 56 | 2 | 16 | 23 | |
| 8 | IL15 levels | PROLV001048 | 47.62 | Protein levels | Lymphocyte | 114 | 2 | 12 | 20 | |
| 9 | PAFAH1B3 levels | PROLV001486 | 47.46 | Protein levels | Lymphocyte | 45 | 2 | 17 | 18 | |
| 10 | IFNG levels | PROLV001019 | 46.96 | Protein levels | Lymphocyte | 30 | 3 | 11 | 38 | |
| 11 | GNLY levels | PROLV000905 | 45.05 | Protein levels | Lymphocyte | 91 | 2 | 14 | 32 | |
| 12 | Papulosquamous disorder | DERMA000015 | 44.74 | Dermatologic | Lymphocyte | 65 | 2 | 12 | 14 | |
| 13 | CD244/CRTAM ratio | PRORT000406 | 43.94 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 14 | ITGAL levels | PROLV001108 | 42.64 | Protein levels | Lymphocyte | 15 | 2 | 17 | 37 | |
| 15 | RPE levels | PROLV001753 | 42.09 | Protein levels | Lymphocyte | 0 | 2 | 15 | 29 | |
| 16 | CD8A levels | PROLV000361 | 41.22 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 17 | Medication, Crohn disease | IMMUN000081 | 40.86 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 18 | CD48/CRTAM ratio | PRORT000463 | 40.80 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 19 | Reimbursement for rheumatic disease | IMMUN000042 | 40.78 | Immunologic | Lymphocyte | 112 | 2 | 16 | 16 | |
| 20 | Heme malignancy, Lymphoid | MALIG000043 | 39.37 | Malignancy | B / plasma cell | 44 | 3 | 15 | 27 | |
| 21 | GNLY/GZMA ratio | PRORT001221 | 38.97 | Protein ratios | Lymphocyte | 41 | 3 | 18 | 47 | |
| 22 | Mouth ulcers | DENTA000010 | 38.84 | Dental | Myeloid | 194 | 4 | 15 | 36 | |
| 23 | GZMH levels | PROLV000949 | 38.02 | Protein levels | Lymphocyte | 95 | 2 | 13 | 29 | |
| 24 | Pain, widespread | MSKEL000042 | 37.81 | Musculoskeletal | Lymphocyte | 0 | 2 | 16 | 37 | |
| 25 | CD160/KLRB1 ratio | PRORT000377 | 37.68 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 26 | LTA levels | PROLV001239 | 37.23 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 27 | CD5/TNFRSF9 ratio | PRORT000468 | 36.88 | Protein ratios | Lymphocyte | 46 | 2 | 16 | 41 | |
| 28 | Lymphocyte | HEMAT000024 | 36.36 | Hematologic | Lymphocyte | 2,286 | 3 | 18 | 34 | |
| 29 | CD160/CXCL16 ratio | PRORT000376 | 36.34 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 30 | GZMA/GZMB ratio | PRORT001257 | 35.70 | Protein ratios | Lymphocyte | 44 | 2 | 12 | 21 | |
| 31 | HLAE/IL15 ratio | PRORT001287 | 35.25 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 32 | CD160/NCR1 ratio | PRORT000378 | 34.78 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 33 | CRTAM/FCRL6 ratio | PRORT000768 | 34.55 | Protein ratios | Lymphocyte | 37 | 2 | 12 | 22 | |
| 34 | CXCL9 levels | PROLV000587 | 34.08 | Protein levels | Lymphocyte | 72 | 2 | 13 | 32 | |
| 35 | Orbital disorder | OPHTH000021 | 33.82 | Ophthalmic | Lymphocyte | 47 | 3 | 15 | 38 | |
| 36 | Autoimmune disease | IMMUN000023 | 33.07 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 37 | CWC15 levels | PROLV000572 | 32.20 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 38 | Psoriatic arthritis | IMMUN000040 | 31.07 | Immunologic | Lymphocyte | 88 | 2 | 15 | 20 | |
| 39 | Immune cell marker, CD8 T cell | HEMAT000023 | 30.98 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 40 | GZMB/IL15 ratio | PRORT001263 | 30.52 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 41 | Thyroid peroxidase antibodies | IMMUN000045 | 30.19 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 42 | SNRPB2 levels | PROLV001910 | 30.14 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 43 | ARHGAP30 levels | PROLV000137 | 29.79 | Protein levels | Lymphocyte | 10 | 3 | 12 | 40 | |
| 44 | KDM3A levels | PROLV001132 | 29.62 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 45 | TNFRSF17 levels | PROLV002066 | 29.50 | Protein levels | B / plasma cell | 116 | 3 | 15 | 18 | |
| 46 | Skin eruption | DERMA000027 | 29.27 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 47 | Contact dermatitis | DERMA000007 | 29.19 | Dermatologic | Lymphocyte | 10 | 2 | 14 | 16 | |
| 48 | APRT levels | PROLV000131 | 29.19 | Protein levels | Lymphocyte | 4 | 3 | 7 | 36 | |
| 49 | Psoriasis | IMMUN000039 | 28.91 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 50 | Medical conditions, allergy etc, none | MISCL000026 | 28.88 | Miscellaneous | Lymphocyte | 251 | 2 | 12 | 15 | |
| 51 | CRTAM/GZMA ratio | PRORT000769 | 28.51 | Protein ratios | Lymphocyte | 34 | 3 | 14 | 33 | |
| 52 | CCL17/PDGFB ratio | PRORT000346 | 28.19 | Protein ratios | Lymphocyte | 23 | 3 | 17 | 37 | |
| 53 | Latent factor, neutrophil and lymphocyte | HEMAT000035 | 27.76 | Hematologic | Myeloid | 675 | 4 | 18 | 31 | |
| 54 | Hyperthyroidism | ENDOC000020 | 27.75 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 55 | CD48/FCRL6 ratio | PRORT000464 | 27.74 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 56 | CRTAM levels | PROLV000530 | 27.64 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 57 | Eosinophil | HEMAT000030 | 27.61 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 58 | CRTAM/TNFRSF9 ratio | PRORT000774 | 27.23 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 59 | LTA4H levels | PROLV001240 | 26.83 | Protein levels | Muscle / cardiac | 0 | 3 | 16 | 38 | |
| 60 | CRTAM/LY9 ratio | PRORT000772 | 26.82 | Protein ratios | Lymphocyte | 31 | 3 | 16 | 28 | |
| 61 | Medication, analgesic or antidepressant | MISCL000033 | 26.47 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 62 | Nasal polyp | RESPI000037 | 26.45 | Respiratory | Lymphocyte | 11 | 2 | 11 | 20 | |
| 63 | CD160 levels | PROLV000311 | 26.44 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 64 | Photodermatitis | DERMA000016 | 26.40 | Dermatologic | Lymphocyte | 2 | 2 | 11 | 29 | |
| 65 | MZB1 levels | PROLV001366 | 26.35 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 66 | Hypothyroidism | ENDOC000021 | 26.29 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 67 | PALM2 levels | PROLV001490 | 26.19 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 68 | CRTAM/ICAM3 ratio | PRORT000770 | 26.13 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 69 | SKAP1 levels | PROLV001872 | 26.07 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 70 | IL15/IL18BP ratio | PRORT001342 | 25.91 | Protein ratios | Lymphocyte | 14 | 2 | 11 | 22 | |
| 71 | S100A11/S100A12 ratio | PRORT001753 | 25.88 | Protein ratios | B / plasma cell | 25 | 4 | 17 | 38 | |
| 72 | GZMA/TNFRSF8 ratio | PRORT001262 | 25.75 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 73 | IL2RB levels | PROLV001070 | 25.68 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 74 | IL15/NCR1 ratio | PRORT001344 | 25.67 | Protein ratios | Lymphocyte | 32 | 2 | 9 | 31 | |
| 75 | Medication, thyroid | ENDOC000002 | 25.54 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 76 | GZMH/KLRD1 ratio | PRORT001264 | 25.43 | Protein ratios | Lymphocyte | 35 | 3 | 13 | 36 | |
| 77 | GZMA/TNFRSF4 ratio | PRORT001261 | 25.33 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 78 | SMNDC1 levels | PROLV001898 | 25.27 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 79 | Neurofibromatosis | NEURO000024 | 25.22 | Neurologic | Lymphocyte | 0 | 3 | 13 | 23 | |
| 80 | GZMB levels | PROLV000948 | 25.15 | Protein levels | Lymphocyte | 108 | 3 | 14 | 28 | |
| 81 | SMPD3 levels | PROLV001902 | 25.13 | Protein levels | Lymphocyte | 11 | 2 | 13 | 22 | |
| 82 | CD244/FCRL6 ratio | PRORT000408 | 25.11 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 83 | DNAJC21 levels | PROLV000634 | 24.99 | Protein levels | Lymphocyte | 2 | 2 | 12 | 18 | |
| 84 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 24.97 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 85 | LAT/LYN ratio | PRORT001422 | 24.82 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 86 | Miscarriage | REPRO000038 | 24.66 | Reproductive | Lymphocyte | 0 | 2 | 15 | 31 | |
| 87 | Atopic dermatitis | DERMA000006 | 24.58 | Dermatologic | Lymphocyte | 115 | 2 | 13 | 11 | |
| 88 | NCR1 levels | PROLV001382 | 24.42 | Protein levels | Lymphocyte | 117 | 2 | 14 | 32 | |
| 89 | Anterior eye disorder | OPHTH000001 | 24.09 | Ophthalmic | Lymphocyte | 38 | 3 | 15 | 21 | |
| 90 | Hypothyroidism, autoimmune | IMMUN000015 | 23.89 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 91 | CXCL16 levels | PROLV000581 | 23.83 | Protein levels | Lymphocyte | 67 | 3 | 13 | 36 | |
| 92 | GZMA/LTA ratio | PRORT001260 | 23.83 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 93 | MAPRE3 levels | PROLV001273 | 23.70 | Protein levels | Lymphocyte | 67 | 3 | 16 | 32 | |
| 94 | CD6 levels | PROLV000349 | 23.68 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 95 | CD7 levels | PROLV000352 | 23.46 | Protein levels | Lymphocyte | 67 | 3 | 12 | 36 | |
| 96 | Drug poisoning | MISCL000036 | 23.31 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 97 | Rheumatoid arthritis, RA | IMMUN000019 | 23.07 | Immunologic | Lymphocyte | 250 | 2 | 16 | 11 | |
| 98 | VEGFB levels | PROLV002158 | 22.81 | Protein levels | Lymphocyte | 54 | 3 | 14 | 35 | |
| 99 | Upper respiratory tract disease | RESPI000042 | 22.73 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 100 | Allergic disease | IMMUN000003 | 22.65 | Immunologic | Lymphocyte | 228 | 2 | 12 | 17 | |
| 101 | Polyarthropathy | MSKEL000019 | 22.55 | Musculoskeletal | Lymphocyte | 65 | 2 | 13 | 23 | |
| 102 | PDCD1 levels | PROLV001515 | 22.10 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 103 | Seborrhoeic dermatitis | DERMA000020 | 21.98 | Dermatologic | Lymphocyte | 98 | 2 | 16 | 19 | |
| 104 | Asthma | IMMUN000005 | 21.93 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 105 | PPM1B levels | PROLV001610 | 21.90 | Protein levels | Lymphocyte | 11 | 2 | 12 | 22 | |
| 106 | Graves disease | IMMUN000027 | 21.73 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 107 | Erythematosquamous dermatosis | DERMA000009 | 21.72 | Dermatologic | Lymphocyte | 92 | 2 | 19 | 20 | |
| 108 | CD79B/TNFRSF4 ratio | PRORT000514 | 21.71 | Protein ratios | B / plasma cell | 45 | 3 | 16 | 20 | |
| 109 | EDAR/EGF ratio | PRORT000965 | 21.63 | Protein ratios | Lymphocyte | 3 | 4 | 12 | 35 | |
| 110 | Stevens-Johnson syndrome, SJS | IMMUN000001 | 21.61 | Immunologic | Lymphocyte | 3 | 2 | 10 | 28 | |
| 111 | Sinusitis | RESPI000039 | 21.50 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 112 | Diabetes, type 1 | IMMUN000012 | 21.32 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 113 | FASLG levels | PROLV000771 | 21.30 | Protein levels | Myeloid | 149 | 2 | 14 | 29 | |
| 114 | GBP1 levels | PROLV000860 | 21.26 | Protein levels | Lymphocyte | 24 | 2 | 13 | 40 | |
| 115 | FCRL6/GZMA ratio | PRORT001137 | 21.24 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 116 | BMP7 levels | PROLV000205 | 21.04 | Protein levels | Lymphocyte | 0 | 2 | 14 | 29 | |
| 117 | PDCD1/TNFRSF8 ratio | PRORT001630 | 21.01 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 118 | Vitamin C | METAB000077 | 20.88 | Metabolites | Lymphocyte | 4 | 2 | 10 | 33 | |
| 119 | CRTAM/KLRD1 ratio | PRORT000771 | 20.80 | Protein ratios | Lymphocyte | 59 | 3 | 13 | 33 | |
| 120 | LHPP levels | PROLV001209 | 20.52 | Protein levels | Lymphocyte | 19 | 2 | 14 | 44 | |
| 121 | BLNK levels | PROLV000200 | 20.15 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 122 | Primary biliary cholangitis, PBC | IMMUN000017 | 20.14 | Immunologic | Lymphocyte | 91 | 3 | 13 | 9 | |
| 123 | Coeliac disease | IMMUN000026 | 20.07 | Immunologic | Lymphocyte | 152 | 2 | 11 | 21 | |
| 124 | NBN levels | PROLV001376 | 20.06 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 125 | KLRB1 levels | PROLV001161 | 19.98 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 126 | UGDH levels | PROLV002138 | 19.76 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 127 | Lichen disorder | DERMA000013 | 19.70 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 128 | ACYP1 levels | PROLV000021 | 19.58 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 129 | PCBD1 levels | PROLV001502 | 19.51 | Protein levels | Hepatocyte | 64 | 4 | 17 | 39 | |
| 130 | Cancer, Lip | MALIG000017 | 19.41 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 131 | CRTAM/PDCD1 ratio | PRORT000773 | 19.37 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 132 | IDO1 levels | PROLV001011 | 19.28 | Protein levels | Myeloid | 66 | 2 | 11 | 32 | |
| 133 | Dissociative disorder | PSYCH000012 | 19.11 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 134 | IL2RA/NCR1 ratio | PRORT001351 | 18.91 | Protein ratios | Lymphocyte | 29 | 3 | 8 | 38 | |
| 135 | Drug hypersensitivity | IMMUN000006 | 18.82 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 136 | Wheeze | RESPI000034 | 18.74 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 137 | BOLA2 or BOLA2B levels | PROLV000208 | 18.69 | Protein levels | Lymphocyte | 3 | 2 | 7 | 24 | |
| 138 | KLF4 levels | PROLV001149 | 18.60 | Protein levels | Lymphocyte | 0 | 2 | 7 | 21 | |
| 139 | TALDO1 levels | PROLV001991 | 18.57 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 140 | CD48/SLAMF7 ratio | PRORT000465 | 18.56 | Protein ratios | Lymphocyte | 35 | 4 | 17 | 42 | |
| 141 | IBD-Inflammatory bowel disease | IMMUN000030 | 18.49 | Immunologic | Lymphocyte | 230 | 4 | 19 | 29 | |
| 142 | CXCL10 levels | PROLV000576 | 18.42 | Protein levels | Myeloid | 89 | 2 | 9 | 19 | |
| 143 | FCRL5/LY96 ratio | PRORT001134 | 18.38 | Protein ratios | B / plasma cell | 39 | 5 | 15 | 23 | |
| 144 | FCRL6/KLRD1 ratio | PRORT001138 | 18.34 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 145 | CLC levels | PROLV000443 | 18.29 | Protein levels | Lymphocyte | 65 | 3 | 19 | 17 | |
| 146 | Primary sclerosing cholangitis, PSC | IMMUN000018 | 18.27 | Immunologic | B / plasma cell | 90 | 3 | 12 | 15 | |
| 147 | CXCL16/NOTCH1 ratio | PRORT000822 | 18.26 | Protein ratios | Vascular | 15 | 3 | 15 | 44 | |
| 148 | MICB_MICA/TEK ratio | PRORT001533 | 18.26 | Protein ratios | Myeloid | 65 | 3 | 12 | 25 | |
| 149 | OSMR levels | PROLV001476 | 18.21 | Protein levels | Lymphocyte | 78 | 3 | 14 | 34 | |
| 150 | Dermatitis and eczema | DERMA000008 | 18.17 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 151 | IFI30 levels | PROLV001014 | 18.07 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 152 | SH2D1A levels | PROLV001852 | 17.76 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 153 | Demyelinating disorder | NEURO000005 | 17.71 | Neurologic | Lymphocyte | — | 2 | 15 | 26 | |
| 154 | PAG1 levels | PROLV001487 | 17.59 | Protein levels | Lymphocyte | 60 | 4 | 18 | 30 | |
| 155 | C5 levels | PROLV000235 | 17.55 | Protein levels | Hepatocyte | 10 | 4 | 15 | 40 | |
| 156 | AHNAK levels | PROLV000062 | 17.51 | Protein levels | Lymphocyte | 17 | 2 | 12 | 33 | |
| 157 | Hyperthyroidism, autoimmune | IMMUN000014 | 17.39 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 158 | CXCL11/DKK1 ratio | PRORT000817 | 17.25 | Protein ratios | Myeloid | 13 | 4 | 15 | 21 | |
| 159 | IPCEF1/SERPINE1 ratio | PRORT001361 | 17.05 | Protein ratios | Lymphocyte | 4 | 4 | 13 | 41 | |
| 160 | Medication, bone metabolism | MSKEL000025 | 17.05 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 161 | CD300A levels | PROLV000329 | 17.03 | Protein levels | Lymphocyte | 39 | 4 | 18 | 41 | |
| 162 | DCTN1/TRIAP1 ratio | PRORT000874 | 16.79 | Protein ratios | Myeloid | 0 | 4 | 16 | 31 | |
| 163 | KIR2DL3 levels | PROLV001142 | 16.77 | Protein levels | Lymphocyte | 134 | 2 | 10 | 19 | |
| 164 | SIT1 levels | PROLV001871 | 16.73 | Protein levels | Lymphocyte | 69 | 2 | 16 | 32 | |
| 165 | PDCD1/TNFRSF4 ratio | PRORT001629 | 16.64 | Protein ratios | Lymphocyte | 11 | 1 | 16 | 18 | |
| 166 | DKK1/IPCEF1 ratio | PRORT000895 | 16.54 | Protein ratios | Lymphocyte | 2 | 3 | 14 | 36 | |
| 167 | CD101 levels | PROLV000308 | 16.52 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 168 | CD27/NBL1 ratio | PRORT000415 | 16.50 | Protein ratios | B / plasma cell | 23 | 3 | 12 | 25 | |
| 169 | ZNF830 levels | PROLV002212 | 16.30 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 170 | IL10 levels | PROLV001042 | 16.27 | Protein levels | Lymphocyte | 50 | 1 | 13 | 25 | |
| 171 | LCN2/PGLYRP1 ratio | PRORT001441 | 16.16 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 172 | KIR3DL1 levels | PROLV001143 | 16.03 | Protein levels | Lymphocyte | 97 | 3 | 13 | 37 | |
| 173 | CCL17/CD69 ratio | PRORT000343 | 15.99 | Protein ratios | Myeloid | 13 | 4 | 18 | 47 | |
| 174 | WARS levels | PROLV002183 | 15.59 | Protein levels | Lymphocyte | 52 | 3 | 12 | 28 | |
| 175 | CD5 levels | PROLV000344 | 15.48 | Protein levels | Lymphocyte | 116 | 3 | 9 | 29 | |
| 176 | BCL2 levels | PROLV000185 | 15.46 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 177 | Pulmonary nodule | RESPI000018 | 15.46 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 178 | PTPRC levels | PROLV001674 | 15.43 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 179 | Chronic respiratory disease | RESPI000003 | 15.27 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 180 | KLRF1 levels | PROLV001163 | 15.24 | Protein levels | Lymphocyte | 134 | 3 | 14 | 15 | |
| 181 | IL5RA/TNFRSF13B ratio | PRORT001352 | 15.19 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 182 | CD40LG/TRAF2 ratio | PRORT000455 | 15.11 | Protein ratios | Lymphocyte | 4 | 2 | 13 | 45 | |
| 183 | PAXX levels | PROLV001499 | 15.08 | Protein levels | Lymphocyte | 14 | 4 | 15 | 31 | |
| 184 | CD27/TGFBR2 ratio | PRORT000417 | 15.05 | Protein ratios | B / plasma cell | 29 | 3 | 10 | 19 | |
| 185 | GRAP2/SRC ratio | PRORT001246 | 14.93 | Protein ratios | Lymphocyte | 10 | 2 | 7 | 13 | |
| 186 | SH2B3/TBL1X ratio | PRORT001784 | 14.91 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 26 | |
| 187 | CRTAP levels | PROLV000531 | 14.85 | Protein levels | B / plasma cell | 49 | 3 | 11 | 21 | |
| 188 | CD5/IL16 ratio | PRORT000467 | 14.71 | Protein ratios | Myeloid | 36 | 4 | 16 | 40 | |
| 189 | EGFL7 levels | PROLV000685 | 14.71 | Protein levels | Lymphocyte | 31 | 2 | 7 | 25 | |
| 190 | MAVS/TBL1X ratio | PRORT001501 | 14.69 | Protein ratios | Lymphocyte | 1 | 2 | 14 | 35 | |
| 191 | EDAR/TACC3 ratio | PRORT000980 | 14.68 | Protein ratios | Myeloid | 9 | 3 | 14 | 21 | |
| 192 | Pregnancy complication, preterm labour | REPRO000034 | 14.52 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 193 | COX5B/GFER ratio | PRORT000716 | 14.46 | Protein ratios | Lymphocyte | 1 | 1 | 12 | 33 | |
| 194 | IL15/KLRD1 ratio | PRORT001343 | 14.45 | Protein ratios | Myeloid | 41 | 4 | 12 | 23 | |
| 195 | PDCD5 levels | PROLV001517 | 14.45 | Protein levels | Lymphocyte | 4 | 3 | 14 | 25 | |
| 196 | Bipolar disorder | PSYCH000023 | 14.44 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 197 | PBLD levels | PROLV001500 | 14.39 | Protein levels | Muscle / cardiac | 5 | 6 | 18 | 62 | |
| 198 | ARHGAP25/RNF41 ratio | PRORT000139 | 14.27 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 199 | Rosacea | DERMA000019 | 14.25 | Dermatologic | Lymphocyte | 37 | 2 | 14 | 19 | |
| 200 | Drug response, carboplatin | MALIG000047 | 14.23 | Malignancy | Lymphocyte | 0 | 1 | 9 | 27 | |
| 201 | Respiratory disease | RESPI000004 | 14.19 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 202 | Cervical intraepithelial lesion | REPRO000002 | 14.19 | Reproductive | Lymphocyte | 23 | 2 | 11 | 25 | |
| 203 | PIKFYVE levels | PROLV001559 | 14.16 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 204 | Family history, asthma | IMMUN000047 | 14.14 | Immunologic | Lymphocyte | 5 | 3 | 17 | 26 | |
| 205 | DEFA1_DEFA1B/PTGDS ratio | PRORT000886 | 13.99 | Protein ratios | Myeloid | 19 | 2 | 13 | 23 | |
| 206 | Pulmonary fibrosis | RESPI000017 | 13.98 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 207 | Infective dermatitis | DERMA000012 | 13.95 | Dermatologic | Lymphocyte | 8 | 3 | 14 | 18 | |
| 208 | Respiratory infection | IMMUN000070 | 13.93 | Immunologic | Lymphocyte | 29 | 2 | 14 | 22 | |
| 209 | Sarcoidosis | IMMUN000080 | 13.91 | Immunologic | Lymphocyte | 82 | 3 | 15 | 37 | |
| 210 | CD83/IL12A_IL12B ratio | PRORT000516 | 13.82 | Protein ratios | B / plasma cell | 66 | 3 | 11 | 16 | |
| 211 | IL18 levels | PROLV001054 | 13.69 | Protein levels | Myeloid | 48 | 2 | 16 | 26 | |
| 212 | Tonsillar and adenoidal disorders | RESPI000040 | 13.69 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 213 | TIGIT levels | PROLV002034 | 13.68 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 214 | TRAF2/WWP2 ratio | PRORT001857 | 13.57 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 51 | |
| 215 | CDH17/PECAM1 ratio | PRORT000549 | 13.48 | Protein ratios | Myeloid | 16 | 1 | 11 | 17 | |
| 216 | ROR1/THBD ratio | PRORT001747 | 13.45 | Protein ratios | Lymphocyte | 10 | 3 | 14 | 38 | |
| 217 | CSNK1D levels | PROLV000542 | 13.42 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 218 | FCRL5/ICAM3 ratio | PRORT001133 | 13.31 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 219 | HMBS/PKLR ratio | PRORT001288 | 13.30 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 220 | CD27/DLL1 ratio | PRORT000412 | 13.29 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 221 | PLXNA4/SRPK2 ratio | PRORT001686 | 13.26 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 222 | Chalazion | OPHTH000017 | 13.24 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 223 | MICB or MICA levels | PROLV001312 | 13.17 | Protein levels | Lymphocyte | 148 | 2 | 12 | 35 | |
| 224 | EDAR/F2R ratio | PRORT000969 | 13.17 | Protein ratios | Platelet | 43 | 3 | 13 | 27 | |
| 225 | KLRK1 levels | PROLV001164 | 13.15 | Protein levels | Lymphocyte | 90 | 2 | 14 | 31 | |
| 226 | Thyroid disorder | ENDOC000023 | 13.11 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 227 | Mosaic chromosomal alteration | MISCL000014 | 13.10 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 228 | IL5RA levels | PROLV001076 | 13.07 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 229 | CD74/NPDC1 ratio | PRORT000506 | 13.06 | Protein ratios | Lymphocyte | 43 | 3 | 22 | 25 | |
| 230 | IGLC2 levels | PROLV001035 | 13.03 | Protein levels | B / plasma cell | 51 | 3 | 15 | 23 | |
| 231 | FUT8/RSPO1 ratio | PRORT001188 | 12.99 | Protein ratios | Lymphocyte | 9 | 2 | 11 | 28 | |
| 232 | CDA levels | PROLV000365 | 12.95 | Protein levels | Lymphocyte | 42 | 2 | 13 | 28 | |
| 233 | CD27/NECTIN4 ratio | PRORT000416 | 12.93 | Protein ratios | Lymphocyte | 15 | 2 | 13 | 34 | |
| 234 | RILP levels | PROLV001734 | 12.93 | Protein levels | Lymphocyte | 22 | 2 | 15 | 42 | |
| 235 | Organic acids | METAB000068 | 12.91 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 236 | KCTD5 levels | PROLV001131 | 12.89 | Protein levels | Lymphocyte | 3 | 1 | 12 | 19 | |
| 237 | TBCA levels | PROLV001998 | 12.88 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 238 | APBB1IP/POLR2F ratio | PRORT000115 | 12.87 | Protein ratios | Myeloid | 11 | 3 | 20 | 34 | |
| 239 | FUT8/TNFSF14 ratio | PRORT001192 | 12.83 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 240 | Sjogren syndrome | IMMUN000043 | 12.77 | Immunologic | Lymphocyte | 33 | 2 | 11 | 18 | |
| 241 | CLPS/PLA2G1B ratio | PRORT000674 | 12.76 | Protein ratios | Lymphocyte | 18 | 3 | 12 | 25 | |
| 242 | MSRA/PRDX5 ratio | PRORT001562 | 12.75 | Protein ratios | Neural / glial | 0 | 5 | 14 | 44 | |
| 243 | JCHAIN levels | PROLV001126 | 12.66 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 244 | Non-albumin protein levels | PROLV001459 | 12.61 | Protein levels | B / plasma cell | 766 | 3 | 12 | 26 | |
| 245 | LCN2/S100A12 ratio | PRORT001444 | 12.61 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 246 | AKT1S1/FHIT ratio | PRORT000064 | 12.60 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 34 | |
| 247 | ATP5IF1/LYN ratio | PRORT000159 | 12.59 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 248 | TSC1 levels | PROLV002112 | 12.57 | Protein levels | Hepatocyte | 18 | 5 | 23 | 29 | |
| 249 | Medication, antispasmodic | GASTR000015 | 12.56 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 250 | LSP1 levels | PROLV001238 | 12.49 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 251 | TP53I3 levels | PROLV002091 | 12.47 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 252 | MZB1/TNFRSF13B ratio | PRORT001568 | 12.39 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 253 | CNTNAP4 levels | PROLV000481 | 12.36 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 254 | LAIR2 levels | PROLV001177 | 12.36 | Protein levels | Lymphocyte | 49 | 2 | 12 | 22 | |
| 255 | Premalignant lesion, Cervix | MALIG000036 | 12.29 | Malignancy | Lymphocyte | 36 | 1 | 8 | 27 | |
| 256 | HHV7 U14 antibody | IMMUN000063 | 12.27 | Immunologic | Lymphocyte | 4 | 1 | 13 | 39 | |
| 257 | FOXO3 levels | PROLV000826 | 12.25 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 258 | Neoplasm, Skin | MALIG000034 | 12.20 | Malignancy | Myeloid | 88 | 4 | 12 | 22 | |
| 259 | EDAR/ERBIN ratio | PRORT000967 | 12.17 | Protein ratios | Myeloid | 31 | 4 | 15 | 24 | |
| 260 | ALB/Globulin ratio | PRORT000067 | 12.14 | Protein ratios | B / plasma cell | 721 | 2 | 16 | 39 | |
| 261 | CA1/HMBS ratio | PRORT000269 | 12.13 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 262 | White blood cell disorder | HEMAT000019 | 12.13 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 263 | BOC levels | PROLV000207 | 12.08 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 264 | CDH17/PTPRM ratio | PRORT000550 | 12.08 | Protein ratios | Lymphocyte | 10 | 1 | 14 | 25 | |
| 265 | Female genital tract polyp | REPRO000009 | 12.07 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 266 | CA3/HMBS ratio | PRORT000280 | 12.07 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 267 | GLO1 levels | PROLV000895 | 12.04 | Protein levels | Lymphocyte | 0 | 2 | 7 | 31 | |
| 268 | STX6 levels | PROLV001969 | 12.04 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 269 | CD27/TNFRSF9 ratio | PRORT000419 | 12.03 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 270 | AHSP/HMBS ratio | PRORT000058 | 11.98 | Protein ratios | Lymphocyte | 33 | 4 | 16 | 48 | |
| 271 | PEAR1/PECAM1 ratio | PRORT001657 | 11.97 | Protein ratios | Myeloid | 24 | 3 | 15 | 24 | |
| 272 | Intelligence decline | PSYCH000005 | 11.96 | Psychiatric | Lymphocyte | 0 | 4 | 10 | 39 | |
| 273 | Gut microbial abundance, Chromatiales | GASTR000024 | 11.83 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 274 | S100A12 levels | PROLV001767 | 11.81 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 275 | Pancreatitis | HPBIL000027 | 11.75 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 276 | LAT/PLXNA4 ratio | PRORT001425 | 11.74 | Protein ratios | Myeloid | 18 | 3 | 12 | 26 | |
| 277 | Disability allowance, none | SOCIO000016 | 11.73 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 278 | IL32 levels | PROLV001072 | 11.70 | Protein levels | Myeloid | 37 | 3 | 14 | 32 | |
| 279 | ENO3 levels | PROLV000707 | 11.68 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 280 | SRP14 levels | PROLV001943 | 11.57 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 281 | APRT/CD63 ratio | PRORT000133 | 11.55 | Protein ratios | Lymphocyte | 22 | 3 | 12 | 41 | |
| 282 | Thyrotoxicosis | ENDOC000024 | 11.53 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 283 | CD27/CD79B ratio | PRORT000411 | 11.42 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 284 | Oral health conditions, none | DENTA000009 | 11.41 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 285 | Gut microbial abundance, Rhodanobacter | GASTR000033 | 11.39 | Gastrointestinal | Hepatocyte | 0 | 2 | 18 | 46 | |
| 286 | NRSN1 levels | PROLV001436 | 11.38 | Protein levels | Lymphocyte | 0 | 2 | 14 | 32 | |
| 287 | CD27 levels | PROLV000324 | 11.34 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 288 | Noninfective gastroenteritis and colitis | GASTR000013 | 11.34 | Gastrointestinal | Myeloid | 78 | 2 | 14 | 27 | |
| 289 | CDH17/SPINT1 ratio | PRORT000551 | 11.32 | Protein ratios | Lymphocyte | 11 | 1 | 12 | 15 | |
| 290 | HSPA1A levels | PROLV000996 | 11.29 | Protein levels | Lymphocyte | 33 | 3 | 14 | 40 | |
| 291 | CAPG levels | PROLV000262 | 11.27 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 292 | SPINK2 levels | PROLV001928 | 11.21 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 293 | GP6/HPCAL1 ratio | PRORT001232 | 11.18 | Protein ratios | Lymphocyte | 1 | 3 | 13 | 26 | |
| 294 | MAVS/MED18 ratio | PRORT001495 | 11.16 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 295 | LBR/POLR2F ratio | PRORT001439 | 11.11 | Protein ratios | Lymphocyte | 5 | 4 | 8 | 36 | |
| 296 | RHOC/TBCB ratio | PRORT001740 | 11.07 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 297 | Hair pigmentation | DERMA000025 | 11.06 | Dermatologic | Melanocyte | 189 | 2 | 7 | 22 | |
| 298 | ENO2/RWDD1 ratio | PRORT001029 | 11.03 | Protein ratios | Lymphocyte | 15 | 4 | 16 | 49 | |
| 299 | FCRL5 levels | PROLV000786 | 11.00 | Protein levels | B / plasma cell | 201 | 5 | 17 | 23 | |
| 300 | PFKM levels | PROLV001541 | 10.96 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 301 | CLEC4D/CLEC6A ratio | PRORT000654 | 10.90 | Protein ratios | Lymphocyte | 4 | 3 | 13 | 35 | |
| 302 | Allergic rhinitis | IMMUN000004 | 10.84 | Immunologic | Lymphocyte | 125 | 2 | 14 | 18 | |
| 303 | Glycan trait | METAB000054 | 10.81 | Metabolites | B / plasma cell | 70 | 2 | 6 | 26 | |
| 304 | KIR2DL2 levels | PROLV001141 | 10.76 | Protein levels | Lymphocyte | 166 | 2 | 14 | 29 | |
| 305 | HLA-A levels | PROLV000972 | 10.75 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 306 | Skin keratoses, actinic | DERMA000021 | 10.73 | Dermatologic | Lymphocyte | 211 | 2 | 10 | 23 | |
| 307 | DNAJA2/PLXNA4 ratio | PRORT000923 | 10.72 | Protein ratios | Lymphocyte | 20 | 6 | 17 | 40 | |
| 308 | GRAP2/MAP4K5 ratio | PRORT001241 | 10.68 | Protein ratios | Lymphocyte | 10 | 2 | 13 | 30 | |
| 309 | BTN3A2 levels | PROLV000220 | 10.66 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 310 | Kidney failure, acute | NEPHR000012 | 10.63 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 311 | IBD-Ulcerative colitis | IMMUN000031 | 10.63 | Immunologic | Myeloid | 239 | 2 | 12 | 28 | |
| 312 | CLEC1B/DAB2 ratio | PRORT000633 | 10.62 | Protein ratios | Lymphocyte | 9 | 4 | 15 | 43 | |
| 313 | Cancer, Skin | MALIG000028 | 10.55 | Malignancy | Lymphocyte | 302 | 3 | 14 | 19 | |
| 314 | TNF/TNFRSF1B ratio | PRORT001844 | 10.52 | Protein ratios | Myeloid | 28 | 3 | 19 | 28 | |
| 315 | IBD-Crohn disease | IMMUN000029 | 10.52 | Immunologic | Myeloid | 279 | 4 | 19 | 18 | |
| 316 | HSPB1 levels | PROLV000997 | 10.52 | Protein levels | Platelet | 16 | 3 | 3 | 13 | |
| 317 | Physical activity, none | BEHAV000005 | 10.48 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 318 | CC2D1A/STAMBP ratio | PRORT000328 | 10.48 | Protein ratios | Lymphocyte | 1 | 1 | 15 | 21 | |
| 319 | Non-cancer illness history | MISCL000030 | 10.41 | Miscellaneous | Lymphocyte | 34 | 2 | 11 | 17 | |
| 320 | Degenerative skin disorder | DERMA000038 | 10.38 | Dermatologic | Lymphocyte | 127 | 3 | 13 | 22 | |
| 321 | GFRA2/IL12A_IL12B ratio | PRORT001210 | 10.38 | Protein ratios | B / plasma cell | 52 | 3 | 12 | 22 | |
| 322 | TTN levels | PROLV002119 | 10.35 | Protein levels | Muscle / cardiac | 13 | 2 | 10 | 23 | |
| 323 | Monoclonal gammopathy | HEMAT000041 | 10.35 | Hematologic | B / plasma cell | 2 | 4 | 15 | 28 | |
| 324 | TNFRSF19 levels | PROLV002067 | 10.34 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 325 | CD300E/EFNA4 ratio | PRORT000431 | 10.33 | Protein ratios | Lymphocyte | 75 | 2 | 10 | 17 | |
| 326 | EBV ZEBRA antibody | IMMUN000061 | 10.24 | Immunologic | Myeloid | — | 3 | 15 | 35 | |
| 327 | FYN levels | PROLV000843 | 10.22 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 328 | ADAM15 levels | PROLV000026 | 10.13 | Protein levels | Lymphocyte | 72 | 2 | 16 | 38 | |
| 329 | LBR/LGALS8 ratio | PRORT001437 | 10.11 | Protein ratios | Lymphocyte | 2 | 2 | 15 | 37 | |
| 330 | Lipid unsaturation | LIPID000079 | 10.09 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 331 | Conjunctivitis | OPHTH000002 | 10.04 | Ophthalmic | Lymphocyte | 26 | 3 | 10 | 30 | |
| 332 | DNAJB2 levels | PROLV000632 | 10.02 | Protein levels | Lymphocyte | 19 | 4 | 17 | 45 | |
| 333 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 10.01 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 334 | RCC1 levels | PROLV001715 | 9.93 | Protein levels | B / plasma cell | 14 | 2 | 8 | 21 | |
| 335 | Erythematous skin disorder | DERMA000010 | 9.90 | Dermatologic | Lymphocyte | 18 | 2 | 19 | 22 | |
| 336 | Hypothyroidism, secondary | ENDOC000015 | 9.88 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 337 | TNFRSF9 levels | PROLV002074 | 9.88 | Protein levels | B / plasma cell | 81 | 1 | 15 | 24 | |
| 338 | EDAR/LAT2 ratio | PRORT000973 | 9.85 | Protein ratios | Myeloid | 1 | 5 | 15 | 23 | |
| 339 | EPHB6/TNFRSF9 ratio | PRORT001038 | 9.84 | Protein ratios | Myeloid | 23 | 3 | 15 | 47 | |
| 340 | DTYMK levels | PROLV000661 | 9.81 | Protein levels | Lymphocyte | 6 | 3 | 9 | 30 | |
| 341 | Polymyalgia rheumatica | IMMUN000038 | 9.78 | Immunologic | Myeloid | 34 | 3 | 11 | 14 | |
| 342 | CLIC5 levels | PROLV000458 | 9.77 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 343 | MAN2B2 levels | PROLV001261 | 9.76 | Protein levels | Hepatocyte | 53 | 4 | 17 | 35 | |
| 344 | VSTM2B levels | PROLV002175 | 9.63 | Protein levels | Lymphocyte | — | 3 | 16 | 34 | |
| 345 | NPDC1/PTGDS ratio | PRORT001594 | 9.60 | Protein ratios | Vascular | 0 | 2 | 12 | 34 | |
| 346 | CD6/EZR ratio | PRORT000484 | 9.59 | Protein ratios | Myeloid | 15 | 5 | 18 | 43 | |
| 347 | Pneumonopathy | RESPI000016 | 9.57 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 348 | RIDA levels | PROLV001733 | 9.56 | Protein levels | Hepatocyte | 51 | 3 | 17 | 29 | |
| 349 | Prospective memory | PSYCH000009 | 9.53 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 350 | DBNL/EDAR ratio | PRORT000865 | 9.49 | Protein ratios | Myeloid | 31 | 4 | 14 | 22 | |
| 351 | SNX2 levels | PROLV001913 | 9.47 | Protein levels | B / plasma cell | 8 | 1 | 6 | 17 | |
| 352 | ATOX1/SNAP29 ratio | PRORT000151 | 9.41 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 353 | CD72 levels | PROLV000354 | 9.41 | Protein levels | B / plasma cell | 84 | 2 | 12 | 31 | |
| 354 | KLRD1/LY9 ratio | PRORT001415 | 9.40 | Protein ratios | Myeloid | 57 | 3 | 13 | 23 | |
| 355 | CD58/MEGF10 ratio | PRORT000477 | 9.40 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 356 | ARHGEF12/DECR1 ratio | PRORT000140 | 9.40 | Protein ratios | Myeloid | 6 | 2 | 10 | 23 | |
| 357 | CD69/EDAR ratio | PRORT000491 | 9.38 | Protein ratios | Myeloid | 21 | 4 | 11 | 22 | |
| 358 | INSR levels | PROLV001094 | 9.34 | Protein levels | Lymphocyte | 42 | 1 | 7 | 30 | |
| 359 | Medication, dermatologic | DERMA000024 | 9.34 | Dermatologic | Lymphocyte | 18 | 2 | 18 | 21 | |
| 360 | TOP2B levels | PROLV002088 | 9.25 | Protein levels | Myeloid | 3 | 3 | 11 | 25 | |
| 361 | Cancer, Endometrium | MALIG000014 | 9.24 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 362 | Operation, respiratory | RESPI000025 | 9.24 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 363 | Vitamin B12 deficiency anaemia | HEMAT000014 | 9.22 | Hematologic | Lymphocyte | 25 | 1 | 6 | 10 | |
| 364 | TPSAB1 levels | PROLV002099 | 9.20 | Protein levels | Lymphocyte | 33 | 2 | 14 | 25 | |
| 365 | Autoimmune hepatitis | IMMUN000024 | 9.18 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 366 | SPESP1 levels | PROLV001926 | 9.17 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 367 | ARG1 levels | PROLV000134 | 9.16 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 368 | SH3GLB2 levels | PROLV001854 | 9.15 | Protein levels | Lymphocyte | 14 | 3 | 17 | 52 | |
| 369 | ENO2/PLXNA4 ratio | PRORT001027 | 9.14 | Protein ratios | Myeloid | 5 | 4 | 13 | 39 | |
| 370 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 9.12 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 371 | SLAMF8 levels | PROLV001877 | 9.03 | Protein levels | Myeloid | 34 | 5 | 12 | 28 | |
| 372 | FCRL2/LY9 ratio | PRORT001130 | 9.01 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 373 | HBEGF/WWP2 ratio | PRORT001272 | 8.96 | Protein ratios | Myeloid | 32 | 3 | 13 | 25 | |
| 374 | METAP1D/PLXNA4 ratio | PRORT001521 | 8.95 | Protein ratios | Myeloid | 5 | 4 | 11 | 24 | |
| 375 | PRG2 levels | PROLV001628 | 8.94 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 376 | CEP85 levels | PROLV000403 | 8.91 | Protein levels | Lymphocyte | 9 | 2 | 11 | 30 | |
| 377 | SUMF1 levels | PROLV001975 | 8.90 | Protein levels | Lymphocyte | 0 | 4 | 12 | 28 | |
| 378 | CD163/ICAM1 ratio | PRORT000381 | 8.89 | Protein ratios | Myeloid | 21 | 5 | 19 | 38 | |
| 379 | EZR levels | PROLV000739 | 8.83 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 380 | BCL2L15 levels | PROLV000188 | 8.82 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 381 | Biliverdin | HPBIL000018 | 8.81 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 382 | HBEGF/PLXNA4 ratio | PRORT001270 | 8.78 | Protein ratios | Myeloid | 60 | 4 | 14 | 23 | |
| 383 | Hair and follicular disorder | DERMA000030 | 8.78 | Dermatologic | Myeloid | 0 | 0 | 2 | 14 | |
| 384 | SLITRK2 levels | PROLV001889 | 8.73 | Protein levels | Lymphocyte | 15 | 3 | 11 | 28 | |
| 385 | PRG3 levels | PROLV001629 | 8.72 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 386 | UCMA levels | PROLV002135 | 8.70 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 387 | Nutritional and metabolic symptoms | METBL000016 | 8.70 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 388 | ICAM3/SLAMF7 ratio | PRORT001328 | 8.67 | Protein ratios | Myeloid | 27 | 3 | 19 | 22 | |
| 389 | Heme malignancy, Plasma cell | MALIG000046 | 8.66 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 390 | MVK/SERPINE1 ratio | PRORT001565 | 8.65 | Protein ratios | Platelet | 10 | 3 | 16 | 31 | |
| 391 | Latent factor, white cell | HEMAT000039 | 8.63 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 392 | ELOA/POLR2F ratio | PRORT001016 | 8.62 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 393 | PIK3IP1/TNFRSF1B ratio | PRORT001667 | 8.59 | Protein ratios | Myeloid | 41 | 3 | 16 | 28 | |
| 394 | TRAF3 levels | PROLV002100 | 8.58 | Protein levels | B / plasma cell | 18 | 2 | 14 | 29 | |
| 395 | GOPC/IRAK4 ratio | PRORT001224 | 8.54 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 32 | |
| 396 | FCRL1/TCL1A ratio | PRORT001126 | 8.50 | Protein ratios | B / plasma cell | 21 | 3 | 14 | 38 | |
| 397 | GP1BA/HBEGF ratio | PRORT001225 | 8.49 | Protein ratios | Myeloid | 30 | 2 | 11 | 18 | |
| 398 | CD244 levels | PROLV000322 | 8.48 | Protein levels | Muscle / cardiac | 28 | 4 | 19 | 38 | |
| 399 | FOLR2/HAVCR2 ratio | PRORT001168 | 8.47 | Protein ratios | Myeloid | 79 | 5 | 20 | 28 | |
| 400 | TDP1 levels | PROLV002007 | 8.46 | Protein levels | Epithelial | 13 | 0 | 3 | 9 | |
| 401 | LAYN/PTPRN2 ratio | PRORT001433 | 8.46 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 402 | SELPLG levels | PROLV001806 | 8.42 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 403 | MAP2K1 levels | PROLV001266 | 8.42 | Protein levels | Lymphocyte | 23 | 3 | 11 | 34 | |
| 404 | XCL1 levels | PROLV002196 | 8.36 | Protein levels | Myeloid | 70 | 2 | 9 | 18 | |
| 405 | CCL5/LAMA4 ratio | PRORT000356 | 8.35 | Protein ratios | Lymphocyte | 8 | 3 | 8 | 17 | |
| 406 | Dietary restriction | DTSUP000009 | 8.33 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 407 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 8.33 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 408 | LY96 levels | PROLV001250 | 8.32 | Protein levels | B / plasma cell | 122 | 4 | 12 | 23 | |
| 409 | PEBP1 levels | PROLV001533 | 8.31 | Protein levels | Lymphocyte | 1 | 3 | 18 | 35 | |
| 410 | GSTA4 levels | PROLV000941 | 8.30 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 411 | PXN levels | PROLV001688 | 8.30 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 412 | B2M levels | PROLV000169 | 8.29 | Protein levels | Lymphocyte | 54 | 3 | 16 | 24 | |
| 413 | NMNAT1 levels | PROLV001411 | 8.24 | Protein levels | Lymphocyte | 18 | 1 | 10 | 26 | |
| 414 | Medication, antipyretic | MISCL000035 | 8.23 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 415 | Immune cell marker, B cell | HEMAT000021 | 8.20 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 416 | TXNDC15 levels | PROLV002124 | 8.17 | Protein levels | B / plasma cell | 86 | 4 | 19 | 38 | |
| 417 | CCL19 levels | PROLV000285 | 8.13 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 418 | Haemoglobin disorder | HEMAT000008 | 8.08 | Hematologic | Myeloid | 0 | 3 | 14 | 40 | |
| 419 | CDKN2D/FOXO1 ratio | PRORT000577 | 8.07 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 420 | ERBIN/LYN ratio | PRORT001049 | 8.04 | Protein ratios | Lymphocyte | 8 | 2 | 14 | 21 | |
| 421 | STIP1 levels | PROLV001962 | 8.00 | Protein levels | Lymphocyte | 3 | 2 | 12 | 38 | |
| 422 | APP/HBEGF ratio | PRORT000126 | 7.92 | Protein ratios | Myeloid | 46 | 5 | 17 | 26 | |
| 423 | ST13 levels | PROLV001951 | 7.87 | Protein levels | Lymphocyte | 2 | 5 | 15 | 39 | |
| 424 | Myo-inositol | METAB000036 | 7.87 | Metabolites | Lymphocyte | 0 | 1 | 10 | 27 | |
| 425 | CASP8/PPP3R1 ratio | PRORT000322 | 7.85 | Protein ratios | Lymphocyte | 5 | 1 | 8 | 25 | |
| 426 | GRHPR levels | PROLV000932 | 7.82 | Protein levels | Stromal / connective | 2 | 5 | 18 | 40 | |
| 427 | External ear disorder | AUDIO000001 | 7.80 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 428 | IPCEF1/SPARC ratio | PRORT001363 | 7.79 | Protein ratios | Myeloid | 11 | 3 | 18 | 31 | |
| 429 | CALCOCO1/IRAG2 ratio | PRORT000297 | 7.75 | Protein ratios | Neural / glial | 0 | 2 | 18 | 34 | |
| 430 | NELL2/SEZ6L ratio | PRORT001585 | 7.74 | Protein ratios | Lymphocyte | 2 | 4 | 16 | 31 | |
| 431 | PTP4A3 levels | PROLV001670 | 7.70 | Protein levels | Myeloid | 2 | 2 | 16 | 21 | |
| 432 | AXIN1/MAVS ratio | PRORT000175 | 7.65 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 433 | BCR/ITGB1BP2 ratio | PRORT000227 | 7.62 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 434 | CCS levels | PROLV000307 | 7.61 | Protein levels | Lymphocyte | 50 | 2 | 13 | 44 | |
| 435 | NME3 levels | PROLV001409 | 7.60 | Protein levels | Myeloid | 92 | 4 | 15 | 35 | |
| 436 | FKBP1B/PRDX5 ratio | PRORT001151 | 7.60 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 31 | |
| 437 | Systemic lupus erythematosus, SLE | IMMUN000020 | 7.59 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 438 | CA2/HMBS ratio | PRORT000275 | 7.59 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 439 | BCR/FOXO1 ratio | PRORT000224 | 7.59 | Protein ratios | Hepatocyte | 15 | 3 | 12 | 23 | |
| 440 | Cancer, Melanoma | MALIG000020 | 7.58 | Malignancy | Lymphocyte | 121 | 2 | 5 | 25 | |
| 441 | Connective tissue disorder | MSKEL000060 | 7.58 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 442 | ITGB2 levels | PROLV001113 | 7.54 | Protein levels | Myeloid | 155 | 2 | 18 | 27 | |
| 443 | DLG4 levels | PROLV000624 | 7.53 | Protein levels | Lymphocyte | 5 | 1 | 5 | 33 | |
| 444 | Granulocyte | HEMAT000031 | 7.52 | Hematologic | Myeloid | 770 | 2 | 8 | 12 | |
| 445 | GCHFR levels | PROLV000867 | 7.52 | Protein levels | Hepatocyte | 2 | 2 | 13 | 40 | |
| 446 | CRYGD levels | PROLV000534 | 7.49 | Protein levels | Hematopoietic progenitor | 17 | 1 | 5 | 20 | |
| 447 | CCL13/CCL17 ratio | PRORT000337 | 7.44 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 448 | Cancer, Lung | MALIG000019 | 7.42 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 449 | Bronchitis | RESPI000001 | 7.32 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 450 | Obstetric trauma | REPRO000039 | 7.32 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 451 | FCER2/TNFRSF9 ratio | PRORT001122 | 7.26 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 452 | ESAM/FUT8 ratio | PRORT001061 | 7.25 | Protein ratios | Lymphocyte | 3 | 2 | 13 | 24 | |
| 453 | Cutaneous and subcutaneous lipoma | DERMA000001 | 7.23 | Dermatologic | Lymphocyte | 0 | 3 | 13 | 26 | |
| 454 | NAP1L4 levels | PROLV001374 | 7.22 | Protein levels | Lymphocyte | 15 | 3 | 9 | 33 | |
| 455 | CD86 levels | PROLV000360 | 7.20 | Protein levels | Myeloid | 72 | 5 | 16 | 20 | |
| 456 | SNX15 levels | PROLV001911 | 7.18 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 457 | FUT8/VEGFC ratio | PRORT001193 | 7.17 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 458 | SEMA4D levels | PROLV001810 | 7.13 | Protein levels | Lymphocyte | 3 | 4 | 9 | 24 | |
| 459 | FOLR2/THY1 ratio | PRORT001170 | 7.13 | Protein ratios | Myeloid | 53 | 4 | 13 | 19 | |
| 460 | CD22/FCRL1 ratio | PRORT000401 | 7.13 | Protein ratios | B / plasma cell | 100 | 2 | 15 | 25 | |
| 461 | Immune cell marker, Monocyte | HEMAT000027 | 7.12 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 462 | FOXO3/SH2B3 ratio | PRORT001179 | 7.08 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 21 | |
| 463 | Cancer, Cervix | MALIG000012 | 7.03 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 464 | UBXN1 levels | PROLV002134 | 7.02 | Protein levels | Lymphocyte | 5 | 4 | 15 | 38 | |
| 465 | F2R/SNX9 ratio | PRORT001082 | 7.00 | Protein ratios | Lymphocyte | 7 | 2 | 13 | 26 | |
| 466 | Iron content, Pancreas | METBL000017 | 6.98 | Metabolic | Muscle / cardiac | 0 | 0 | 2 | 11 | |
| 467 | GZMA levels | PROLV000947 | 6.97 | Protein levels | Myeloid | 161 | 3 | 5 | 15 | |
| 468 | Pregnancy complication, vomiting | REPRO000035 | 6.96 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 469 | CA5A/GSTA1 ratio | PRORT000287 | 6.95 | Protein ratios | Hepatocyte | 27 | 1 | 13 | 21 | |
| 470 | CCL5/SELP ratio | PRORT000358 | 6.94 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 471 | Myasthenia gravis | IMMUN000035 | 6.94 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 472 | EDAR/SNAP23 ratio | PRORT000978 | 6.93 | Protein ratios | Myeloid | 33 | 3 | 15 | 20 | |
| 473 | Keloid and scarring | DERMA000041 | 6.92 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 474 | GMPR2 levels | PROLV000903 | 6.90 | Protein levels | Lymphocyte | 3 | 3 | 11 | 40 | |
| 475 | TNFSF12 levels | PROLV002077 | 6.90 | Protein levels | Lymphocyte | 61 | 2 | 7 | 31 | |
| 476 | TYRP1 levels | PROLV002130 | 6.90 | Protein levels | Myeloid | 94 | 5 | 11 | 17 | |
| 477 | SIRT1 levels | PROLV001869 | 6.88 | Protein levels | Muscle / cardiac | 6 | 2 | 11 | 20 | |
| 478 | F5 levels | PROLV000747 | 6.87 | Protein levels | Muscle / cardiac | 0 | 3 | 14 | 28 | |
| 479 | SNAP23/TXLNA ratio | PRORT001795 | 6.86 | Protein ratios | Hepatocyte | 0 | 2 | 12 | 24 | |
| 480 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 6.86 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 481 | CC2D1A/TMSB10 ratio | PRORT000330 | 6.85 | Protein ratios | Myeloid | 4 | 3 | 11 | 27 | |
| 482 | AK1 levels | PROLV000070 | 6.78 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 483 | YOD1 levels | PROLV002206 | 6.78 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 484 | Female genital dysplasia | REPRO000007 | 6.78 | Reproductive | Hepatocyte | 17 | 2 | 8 | 22 | |
| 485 | HLA-E levels | PROLV000976 | 6.77 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 486 | FCRL5/TNFRSF13B ratio | PRORT001136 | 6.69 | Protein ratios | B / plasma cell | 59 | 4 | 15 | 23 | |
| 487 | CALCOCO1/CRACR2A ratio | PRORT000293 | 6.68 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 488 | CD302/IL12A_IL12B ratio | PRORT000438 | 6.68 | Protein ratios | B / plasma cell | 43 | 4 | 9 | 19 | |
| 489 | CALCOCO1/IKBKG ratio | PRORT000295 | 6.67 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 490 | TBCB/TBCC ratio | PRORT001827 | 6.67 | Protein ratios | Myeloid | 1 | 2 | 10 | 23 | |
| 491 | IL2RA levels | PROLV001069 | 6.67 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 492 | LBR levels | PROLV001189 | 6.66 | Protein levels | Lymphocyte | 6 | 5 | 12 | 47 | |
| 493 | TOR1AIP1 levels | PROLV002089 | 6.66 | Protein levels | Lymphocyte | 3 | 4 | 12 | 44 | |
| 494 | Digestive system symptoms | GASTR000044 | 6.65 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 495 | CDSN/WFDC12 ratio | PRORT000585 | 6.64 | Protein ratios | Lymphocyte | 41 | 3 | 12 | 32 | |
| 496 | Intracranial volume | NIMAG000025 | 6.63 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 497 | JAM2/TNFRSF14 ratio | PRORT001399 | 6.61 | Protein ratios | Platelet | 2 | 6 | 12 | 25 | |
| 498 | FUT8 levels | PROLV000839 | 6.59 | Protein levels | Myeloid | 28 | 3 | 8 | 30 | |
| 499 | Cutaneous haemangioma | DERMA000003 | 6.58 | Dermatologic | Myeloid | 1 | 1 | 7 | 12 | |
| 500 | Allergic conjunctivitis | IMMUN000002 | 6.56 | Immunologic | Lymphocyte | 34 | 2 | 8 | 28 | |
| 501 | AHCY/HSPA1A ratio | PRORT000055 | 6.55 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 502 | Aplastic anaemia | HEMAT000004 | 6.53 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 503 | Vaccination adverse effects | IMMUN000008 | 6.53 | Immunologic | Muscle / cardiac | 0 | 3 | 7 | 37 | |
| 504 | PPP1R14D levels | PROLV001615 | 6.52 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 505 | CLEC1B/HBEGF ratio | PRORT000638 | 6.52 | Protein ratios | Myeloid | 60 | 2 | 15 | 15 | |
| 506 | CA1 levels | PROLV000239 | 6.52 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 507 | Pre-existing hypertension, pregnancy | VASCU000044 | 6.51 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 508 | BAG6/BMP6 ratio | PRORT000200 | 6.50 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 38 | |
| 509 | EDIL3 levels | PROLV000675 | 6.50 | Protein levels | Lymphocyte | 4 | 2 | 10 | 30 | |
| 510 | LYN/SIRT2 ratio | PRORT001472 | 6.49 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 511 | CD27/TNFRSF13B ratio | PRORT000418 | 6.49 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 512 | Tyrosine metabolites | METAB000016 | 6.47 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 513 | EFNA4/TNFRSF9 ratio | PRORT000992 | 6.46 | Protein ratios | B / plasma cell | 16 | 3 | 18 | 25 | |
| 514 | Obesity | METBL000008 | 6.45 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 515 | CCL5/TACC3 ratio | PRORT000359 | 6.45 | Protein ratios | Myeloid | 3 | 7 | 17 | 29 | |
| 516 | GSTA1/PBLD ratio | PRORT001250 | 6.44 | Protein ratios | Hepatocyte | 65 | 3 | 13 | 30 | |
| 517 | ITGB1BP2/TIA1 ratio | PRORT001389 | 6.44 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 518 | SUOX levels | PROLV001977 | 6.44 | Protein levels | Hepatocyte | 27 | 1 | 13 | 31 | |
| 519 | LPCAT2/SERPINB8 ratio | PRORT001459 | 6.42 | Protein ratios | Myeloid | 19 | 4 | 11 | 23 | |
| 520 | TNFRSF13B/TNFRSF9 ratio | PRORT001847 | 6.42 | Protein ratios | B / plasma cell | 19 | 2 | 14 | 28 | |
| 521 | KIFBP/LYN ratio | PRORT001403 | 6.41 | Protein ratios | Myeloid | 9 | 4 | 14 | 37 | |
| 522 | Hospital discharge | MISCL000023 | 6.41 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 523 | CD40LG/TNFSF14 ratio | PRORT000454 | 6.41 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 524 | Chest pain | CARDI000052 | 6.39 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 525 | CASP10 levels | PROLV000266 | 6.39 | Protein levels | Lymphocyte | 3 | 4 | 11 | 33 | |
| 526 | FOXO1/USP8 ratio | PRORT001177 | 6.38 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 527 | Nail disorder | DERMA000033 | 6.37 | Dermatologic | Lymphocyte | 1 | 2 | 11 | 24 | |
| 528 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 6.35 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 529 | TNFSF13B levels | PROLV002079 | 6.34 | Protein levels | B / plasma cell | 111 | 3 | 10 | 29 | |
| 530 | CASP1 levels | PROLV000265 | 6.34 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 531 | DNMBP/WWP2 ratio | PRORT000934 | 6.34 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 532 | TYRO3 levels | PROLV002129 | 6.33 | Protein levels | Lymphocyte | 36 | 1 | 9 | 30 | |
| 533 | APRT/MIF ratio | PRORT000135 | 6.33 | Protein ratios | Lymphocyte | 2 | 4 | 14 | 40 | |
| 534 | RAPGEF2 levels | PROLV001705 | 6.31 | Protein levels | Stromal / connective | 2 | 2 | 17 | 40 | |
| 535 | HNRNPUL1 levels | PROLV000983 | 6.29 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 536 | BSG/IL12A_IL12B ratio | PRORT000247 | 6.29 | Protein ratios | B / plasma cell | 54 | 3 | 7 | 14 | |
| 537 | DKK1/PPCDC ratio | PRORT000899 | 6.25 | Protein ratios | Myeloid | 14 | 2 | 10 | 16 | |
| 538 | PLXDC1 levels | PROLV001583 | 6.25 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 539 | Liver fibrosis and cirrhosis | HPBIL000007 | 6.25 | Hepatopancreatobiliary | B / plasma cell | 11 | 4 | 13 | 32 | |
| 540 | ICAM3/LY9 ratio | PRORT001326 | 6.22 | Protein ratios | B / plasma cell | 36 | 3 | 13 | 42 | |
| 541 | Orofacial cleft | DENTA000001 | 6.22 | Dental | Neural / glial | 0 | 1 | 10 | 17 | |
| 542 | DGKA levels | PROLV000616 | 6.22 | Protein levels | Lymphocyte | 0 | 1 | 10 | 32 | |
| 543 | LRRC37A2 levels | PROLV001233 | 6.21 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 544 | SLAMF7 levels | PROLV001876 | 6.21 | Protein levels | Myeloid | 126 | 3 | 7 | 14 | |
| 545 | EDAR/YES1 ratio | PRORT000985 | 6.20 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 546 | Basophil | HEMAT000029 | 6.20 | Hematologic | Myeloid | 728 | 2 | 8 | 13 | |
| 547 | Cancer, Kidney | MALIG000016 | 6.20 | Malignancy | Pancreatic epithelium | 1 | 0 | 6 | 12 | |
| 548 | Prurigo | DERMA000017 | 6.20 | Dermatologic | Lymphocyte | 1 | 2 | 8 | 29 | |
| 549 | ADH4/CA5A ratio | PRORT000038 | 6.19 | Protein ratios | Hepatocyte | 30 | 2 | 14 | 26 | |
| 550 | MEGF10 levels | PROLV001293 | 6.19 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 551 | CXCL11/SDC4 ratio | PRORT000819 | 6.18 | Protein ratios | Myeloid | 15 | 4 | 10 | 19 | |
| 552 | Tubulointerstitial kidney disease | NEPHR000025 | 6.17 | Nephrourologic | Lymphocyte | 2 | 0 | 8 | 17 | |
| 553 | Epigenetic age acceleration | AGING000002 | 6.17 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 554 | BIN1 levels | PROLV000196 | 6.16 | Protein levels | Muscle / cardiac | 0 | 2 | 10 | 18 | |
| 555 | ITGB7 levels | PROLV001116 | 6.16 | Protein levels | Hepatocyte | 157 | 4 | 17 | 37 | |
| 556 | Medication, chronic lung disease | RESPI000006 | 6.14 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 557 | CRYBB1 levels | PROLV000532 | 6.12 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 558 | TP53BP1 levels | PROLV002090 | 6.11 | Protein levels | B / plasma cell | 66 | 2 | 10 | 28 | |
| 559 | DXO levels | PROLV000665 | 6.11 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 560 | CRACR2A/IRAG2 ratio | PRORT000740 | 6.08 | Protein ratios | Hepatocyte | 1 | 3 | 11 | 37 | |
| 561 | IGF1R levels | PROLV001026 | 6.07 | Protein levels | Lymphocyte | 167 | 2 | 12 | 32 | |
| 562 | IGBP1 levels | PROLV001023 | 6.07 | Protein levels | Lymphocyte | 1 | 3 | 12 | 33 | |
| 563 | HEXIM1/TRIAP1 ratio | PRORT001281 | 6.06 | Protein ratios | Myeloid | 2 | 3 | 17 | 30 | |
| 564 | CXCL5/MESD ratio | PRORT000828 | 6.06 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 565 | F2R/TNFRSF14 ratio | PRORT001085 | 6.06 | Protein ratios | Lymphocyte | 15 | 3 | 9 | 34 | |
| 566 | OLFM4 levels | PROLV001466 | 6.06 | Protein levels | Myeloid | 42 | 2 | 8 | 17 | |
| 567 | EDAR/IPCEF1 ratio | PRORT000970 | 6.05 | Protein ratios | Myeloid | 32 | 3 | 15 | 18 | |
| 568 | CD48 levels | PROLV000343 | 6.04 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 569 | IL16/NADK ratio | PRORT001345 | 6.04 | Protein ratios | Myeloid | 4 | 2 | 7 | 21 | |
| 570 | CDSN/LY6D ratio | PRORT000583 | 6.03 | Protein ratios | Cutaneous epithelium | 33 | 2 | 18 | 32 | |
| 571 | SNAP29/VEGFC ratio | PRORT001800 | 6.03 | Protein ratios | Lymphocyte | 5 | 2 | 8 | 38 | |
| 572 | BCR/DECR1 ratio | PRORT000223 | 6.03 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 31 | |
| 573 | LMNB2 levels | PROLV001218 | 6.03 | Protein levels | Myeloid | 6 | 1 | 14 | 18 | |
| 574 | GORASP2 levels | PROLV000911 | 5.98 | Protein levels | Vascular | 13 | 2 | 7 | 27 | |
| 575 | CXCL5/PLXNA4 ratio | PRORT000829 | 5.98 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 576 | PARP1 levels | PROLV001497 | 5.98 | Protein levels | Lymphocyte | 2 | 6 | 14 | 35 | |
| 577 | IL7 levels | PROLV001080 | 5.94 | Protein levels | Lymphocyte | 7 | 4 | 10 | 33 | |
| 578 | SERPINB13 levels | PROLV001824 | 5.93 | Protein levels | Hepatocyte | 0 | 1 | 11 | 15 | |
| 579 | ICAM3 levels | PROLV001006 | 5.91 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 580 | APP/LAMA4 ratio | PRORT000127 | 5.91 | Protein ratios | Lymphocyte | 7 | 3 | 9 | 26 | |
| 581 | CHMP1A/RHOC ratio | PRORT000613 | 5.90 | Protein ratios | Myeloid | 18 | 3 | 13 | 19 | |
| 582 | OCLN levels | PROLV001461 | 5.89 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 583 | F11R/PLXNA4 ratio | PRORT001073 | 5.88 | Protein ratios | Lymphocyte | 16 | 3 | 12 | 20 | |
| 584 | Glutathione metabolites | METAB000006 | 5.86 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 585 | THBS2 levels | PROLV002026 | 5.86 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 586 | Neutrophil | HEMAT000034 | 5.83 | Hematologic | Myeloid | 2,361 | 4 | 8 | 13 | |
| 587 | BLMH/SERPINE1 ratio | PRORT000237 | 5.83 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 588 | KLRB1/KLRD1 ratio | PRORT001414 | 5.81 | Protein ratios | Myeloid | 47 | 4 | 15 | 24 | |
| 589 | CPXM1/HBEGF ratio | PRORT000733 | 5.81 | Protein ratios | Myeloid | 44 | 4 | 11 | 22 | |
| 590 | APP/BIN2 ratio | PRORT000120 | 5.80 | Protein ratios | Myeloid | 3 | 2 | 13 | 34 | |
| 591 | Medication, analgesic | MISCL000034 | 5.78 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 592 | PTPRS levels | PROLV001681 | 5.75 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 593 | CCL4 levels | PROLV000297 | 5.74 | Protein levels | Myeloid | 72 | 2 | 5 | 8 | |
| 594 | KLRD1 levels | PROLV001162 | 5.73 | Protein levels | Myeloid | 163 | 2 | 11 | 15 | |
| 595 | Branched-chain amino acid metabolites | METAB000004 | 5.70 | Metabolites | Lymphocyte | 0 | 1 | 8 | 31 | |
| 596 | MAP2K6/TBL1X ratio | PRORT001487 | 5.69 | Protein ratios | Myeloid | 10 | 4 | 12 | 28 | |
| 597 | ICAM1 levels | PROLV001004 | 5.69 | Protein levels | Myeloid | 52 | 3 | 15 | 19 | |
| 598 | SNAP23/TBL1X ratio | PRORT001794 | 5.67 | Protein ratios | Myeloid | 9 | 3 | 13 | 22 | |
| 599 | LTA/LTBR ratio | PRORT001463 | 5.67 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 600 | Medical condition | MISCL000028 | 5.67 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 601 | Pregnancy complication, ectopic | REPRO000028 | 5.66 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 602 | IL1RL1 levels | PROLV001063 | 5.65 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 603 | CD244/GP1BA ratio | PRORT000409 | 5.64 | Protein ratios | Hematopoietic progenitor | 5 | 2 | 12 | 34 | |
| 604 | CD244/TREML2 ratio | PRORT000410 | 5.64 | Protein ratios | Myeloid | 33 | 5 | 16 | 23 | |
| 605 | Heme malignancy, Lymphoma | MALIG000044 | 5.62 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 606 | NMT1 levels | PROLV001412 | 5.62 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 607 | NT5C levels | PROLV001438 | 5.59 | Protein levels | Lymphocyte | 34 | 2 | 8 | 33 | |
| 608 | SPTLC1 levels | PROLV001941 | 5.58 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 609 | EDAR/PRDX5 ratio | PRORT000974 | 5.57 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 610 | AIDA levels | PROLV000067 | 5.57 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 611 | EBAG9/EDAR ratio | PRORT000957 | 5.56 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 612 | KYNU/SCLY ratio | PRORT001416 | 5.55 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 613 | Bleeding gums | DENTA000011 | 5.54 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 614 | NT5C1A levels | PROLV001439 | 5.54 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 615 | TNFSF12/TNFSF13 ratio | PRORT001856 | 5.52 | Protein ratios | Lymphocyte | 20 | 2 | 13 | 35 | |
| 616 | PLXNB3/SNAP23 ratio | PRORT001691 | 5.52 | Protein ratios | Myeloid | 0 | 5 | 13 | 36 | |
| 617 | SLAMF7/TXNDC15 ratio | PRORT001789 | 5.51 | Protein ratios | Hepatocyte | 28 | 3 | 11 | 24 | |
| 618 | Osteochondrodysplasia | MSKEL000054 | 5.47 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 619 | QDPR levels | PROLV001692 | 5.47 | Protein levels | Lymphocyte | 0 | 5 | 14 | 33 | |
| 620 | Muscular dystrophy | MSKEL000028 | 5.45 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 621 | OSM/TGFA ratio | PRORT001617 | 5.43 | Protein ratios | Myeloid | 11 | 2 | 11 | 22 | |
| 622 | ECM1 levels | PROLV000672 | 5.42 | Protein levels | Muscle / cardiac | 18 | 4 | 13 | 49 | |
| 623 | CD84/F2R ratio | PRORT000523 | 5.42 | Protein ratios | Lymphocyte | 20 | 3 | 13 | 33 | |
| 624 | CSF2 levels | PROLV000538 | 5.42 | Protein levels | Muscle / cardiac | 12 | 1 | 2 | 21 | |
| 625 | Glutamate metabolites | METAB000005 | 5.41 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 626 | LGALS8 levels | PROLV001206 | 5.41 | Protein levels | Vascular | 13 | 3 | 8 | 21 | |
| 627 | IL16 levels | PROLV001050 | 5.39 | Protein levels | Muscle / cardiac | 38 | 2 | 7 | 27 | |
| 628 | WASL levels | PROLV002187 | 5.36 | Protein levels | B / plasma cell | 54 | 2 | 8 | 16 | |
| 629 | MMP9/PLAUR ratio | PRORT001548 | 5.36 | Protein ratios | Myeloid | 53 | 3 | 7 | 15 | |
| 630 | TCL1A/TNFRSF13C ratio | PRORT001829 | 5.35 | Protein ratios | B / plasma cell | 23 | 2 | 14 | 31 | |
| 631 | PLXNA4/SUSD1 ratio | PRORT001687 | 5.35 | Protein ratios | Lymphocyte | 1 | 2 | 7 | 26 | |
| 632 | PGR levels | PROLV001548 | 5.34 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 633 | CXCL3/CXCL5 ratio | PRORT000825 | 5.33 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 634 | LAG3/VCAM1 ratio | PRORT001418 | 5.33 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 635 | PPP1R2/TBL1X ratio | PRORT001706 | 5.31 | Protein ratios | Myeloid | 14 | 3 | 13 | 18 | |
| 636 | CD109 levels | PROLV000309 | 5.27 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 637 | GALNT10/SEMA7A ratio | PRORT001202 | 5.26 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 638 | APRT/PSME1 ratio | PRORT000137 | 5.26 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 639 | APRT/EREG ratio | PRORT000134 | 5.23 | Protein ratios | Myeloid | 4 | 2 | 11 | 23 | |
| 640 | CD27/FCRL5 ratio | PRORT000413 | 5.22 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 641 | HTRA2/SIAE ratio | PRORT001311 | 5.21 | Protein ratios | Lymphocyte | 8 | 5 | 13 | 32 | |
| 642 | CCL3 levels | PROLV000296 | 5.21 | Protein levels | Myeloid | 77 | 3 | 9 | 19 | |
| 643 | Cannabis use | PSYCH000045 | 5.20 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 644 | Dyspnoea | RESPI000028 | 5.20 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 645 | IL18BP/ROR1 ratio | PRORT001346 | 5.20 | Protein ratios | Myeloid | 6 | 3 | 14 | 30 | |
| 646 | CANT1/GSTA1 ratio | PRORT000306 | 5.19 | Protein ratios | Hepatocyte | 51 | 2 | 17 | 36 | |
| 647 | CA5A/KRT18 ratio | PRORT000288 | 5.19 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 648 | RAP1A levels | PROLV001704 | 5.19 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 649 | PPP1R12A/VEGFC ratio | PRORT001704 | 5.18 | Protein ratios | Lymphocyte | 3 | 4 | 15 | 46 | |
| 650 | SOD1 levels | PROLV001916 | 5.14 | Protein levels | Lymphocyte | 1 | 2 | 10 | 33 | |
| 651 | Disability allowance | SOCIO000019 | 5.14 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 652 | IL12A or IL12B levels | PROLV001044 | 5.11 | Protein levels | Myeloid | 210 | 4 | 10 | 21 | |
| 653 | Leukocyte | HEMAT000018 | 5.11 | Hematologic | Myeloid | 2,427 | 3 | 11 | 17 | |
| 654 | Medication, anti-asthmatic | IMMUN000082 | 5.10 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 655 | Biliary cirrhosis | HPBIL000005 | 5.10 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 656 | Erythrocyte | HEMAT000005 | 5.09 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 657 | Congenital malformation | REPRO000003 | 5.08 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 658 | MMP1 levels | PROLV001321 | 5.06 | Protein levels | Hematopoietic progenitor | 57 | 6 | 11 | 19 | |
| 659 | PDGFB/TNFSF13 ratio | PRORT001649 | 5.05 | Protein ratios | Neural / glial | 1 | 5 | 15 | 31 | |
| 660 | MAD1L1/POLR2F ratio | PRORT001475 | 5.05 | Protein ratios | Myeloid | 0 | 4 | 10 | 14 | |
| 661 | EGF/TNFSF14 ratio | PRORT000999 | 5.04 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 662 | APP/PPP1R12A ratio | PRORT000130 | 5.03 | Protein ratios | Myeloid | 7 | 3 | 13 | 29 | |
| 663 | CRACR2A/LBR ratio | PRORT000741 | 5.02 | Protein ratios | Myeloid | 0 | 3 | 17 | 17 | |
| 664 | Digestive system disorder | GASTR000006 | 5.01 | Gastrointestinal | Vascular | 60 | 0 | 7 | 16 | |
| 665 | C8B levels | PROLV000237 | 5.01 | Protein levels | Hepatocyte | 31 | 3 | 16 | 31 | |
| 666 | Juvenile arthritis | IMMUN000032 | 5.00 | Immunologic | Salivary epithelium | 29 | 1 | 8 | 31 | |
| 667 | PSAPL1 levels | PROLV001654 | 5.00 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 668 | Dizziness and giddiness | AUDIO000020 | 4.99 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 669 | GFRA2 levels | PROLV000877 | 4.98 | Protein levels | Myeloid | 66 | 3 | 18 | 20 | |
| 670 | PTPN1/WWP2 ratio | PRORT001718 | 4.98 | Protein ratios | Muscle / cardiac | 12 | 2 | 14 | 27 | |
| 671 | ESAM/TNFRSF14 ratio | PRORT001069 | 4.98 | Protein ratios | Vascular | 1 | 3 | 12 | 27 | |
| 672 | Household income | SOCIO000026 | 4.97 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 673 | PRL levels | PROLV001635 | 4.96 | Protein levels | Lymphocyte | 17 | 2 | 9 | 27 | |
| 674 | ITGB1BP2/USP8 ratio | PRORT001390 | 4.95 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 675 | DRG2/SEMA4D ratio | PRORT000949 | 4.93 | Protein ratios | Hepatocyte | 6 | 3 | 17 | 35 | |
| 676 | CALCOCO1/TJAP1 ratio | PRORT000303 | 4.93 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 677 | DEFA1_DEFA1B/LCN2 ratio | PRORT000885 | 4.91 | Protein ratios | Myeloid | 58 | 4 | 9 | 16 | |
| 678 | SERPINE1/USP8 ratio | PRORT001779 | 4.89 | Protein ratios | Lymphocyte | 0 | 4 | 16 | 40 | |
| 679 | CRKL/MANF ratio | PRORT000764 | 4.89 | Protein ratios | Myeloid | 5 | 4 | 13 | 18 | |
| 680 | Telomere length | AGING000001 | 4.89 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 681 | CCN2/DKK1 ratio | PRORT000362 | 4.89 | Protein ratios | Muscle / cardiac | 7 | 4 | 13 | 29 | |
| 682 | CCL13/CCL8 ratio | PRORT000339 | 4.88 | Protein ratios | Myeloid | 0 | 2 | 7 | 27 | |
| 683 | METAP2/RILP ratio | PRORT001525 | 4.87 | Protein ratios | Myeloid | 0 | 3 | 11 | 18 | |
| 684 | DAB2/ERBIN ratio | PRORT000835 | 4.85 | Protein ratios | Muscle / cardiac | 0 | 5 | 15 | 36 | |
| 685 | TNFRSF13B/TNFSF13B ratio | PRORT001848 | 4.83 | Protein ratios | B / plasma cell | 5 | 2 | 9 | 14 | |
| 686 | CASP10/ING1 ratio | PRORT000311 | 4.83 | Protein ratios | Lymphocyte | 4 | 3 | 11 | 36 | |
| 687 | ZNRD2 levels | PROLV002213 | 4.83 | Protein levels | B / plasma cell | 62 | 2 | 14 | 25 | |
| 688 | MMP8/OLR1 ratio | PRORT001543 | 4.82 | Protein ratios | Myeloid | 9 | 3 | 10 | 21 | |
| 689 | CPXM1/SPARC ratio | PRORT000736 | 4.81 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 690 | LBP levels | PROLV001188 | 4.79 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 691 | FKBP4 levels | PROLV000809 | 4.78 | Protein levels | Lymphocyte | 2 | 5 | 15 | 40 | |
| 692 | MMP9/PLTP ratio | PRORT001549 | 4.77 | Protein ratios | Myeloid | 15 | 4 | 15 | 30 | |
| 693 | Iris and ciliary body disorder | OPHTH000005 | 4.76 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 694 | GLA levels | PROLV000893 | 4.75 | Protein levels | Lymphocyte | 2 | 3 | 6 | 30 | |
| 695 | PADI4 levels | PROLV001484 | 4.73 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 696 | PSME2 levels | PROLV001659 | 4.73 | Protein levels | Vascular | 1 | 4 | 9 | 30 | |
| 697 | FCGR2B levels | PROLV000779 | 4.73 | Protein levels | Myeloid | 47 | 1 | 8 | 18 | |
| 698 | DAB2/FKBP1B ratio | PRORT000836 | 4.72 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 699 | DAG1/DBNL ratio | PRORT000844 | 4.72 | Protein ratios | Muscle / cardiac | 1 | 4 | 15 | 25 | |
| 700 | Handedness | BEHAV000003 | 4.70 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 701 | ESR1 levels | PROLV000735 | 4.69 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 702 | RNASEH2A levels | PROLV001741 | 4.69 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 703 | CD5L levels | PROLV000348 | 4.69 | Protein levels | B / plasma cell | 208 | 2 | 11 | 26 | |
| 704 | CKAP4/TNFRSF4 ratio | PRORT000624 | 4.67 | Protein ratios | Hepatocyte | 21 | 2 | 10 | 35 | |
| 705 | Ankylosing spondylitis | IMMUN000022 | 4.67 | Immunologic | Lymphocyte | 83 | 4 | 8 | 19 | |
| 706 | CD22/TCL1A ratio | PRORT000404 | 4.65 | Protein ratios | B / plasma cell | 71 | 3 | 13 | 24 | |
| 707 | Osteopenia | MSKEL000009 | 4.64 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 708 | Cancer, Respiratory system | MALIG000027 | 4.63 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 709 | Enamel hypoplasia | DENTA000002 | 4.60 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 710 | UNC5D levels | PROLV002141 | 4.60 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 711 | CHMP1A/EREG ratio | PRORT000612 | 4.60 | Protein ratios | Myeloid | 33 | 3 | 14 | 21 | |
| 712 | FHIT/GLOD4 ratio | PRORT001144 | 4.59 | Protein ratios | Lymphocyte | 0 | 1 | 6 | 29 | |
| 713 | APEX1 levels | PROLV000114 | 4.59 | Protein levels | Muscle / cardiac | 6 | 4 | 12 | 38 | |
| 714 | ABL1/CC2D1A ratio | PRORT000008 | 4.59 | Protein ratios | Lymphocyte | 4 | 1 | 7 | 21 | |
| 715 | SKAP2/VSIR ratio | PRORT001788 | 4.59 | Protein ratios | Myeloid | 7 | 4 | 17 | 18 | |
| 716 | CXCL11 levels | PROLV000577 | 4.57 | Protein levels | Myeloid | 47 | 4 | 9 | 18 | |
| 717 | BSG/LY9 ratio | PRORT000249 | 4.56 | Protein ratios | B / plasma cell | 12 | 1 | 6 | 19 | |
| 718 | PARK7 levels | PROLV001496 | 4.56 | Protein levels | Lymphocyte | 0 | 5 | 13 | 38 | |
| 719 | PROK1 levels | PROLV001638 | 4.55 | Protein levels | Myeloid | 74 | 2 | 15 | 17 | |
| 720 | EDAR/ENO2 ratio | PRORT000966 | 4.55 | Protein ratios | Myeloid | 31 | 4 | 7 | 19 | |
| 721 | DKK1/LGALS8 ratio | PRORT000896 | 4.55 | Protein ratios | Myeloid | 21 | 2 | 11 | 21 | |
| 722 | Cancer, Testis | MALIG000031 | 4.54 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 723 | CCN2/TACC3 ratio | PRORT000369 | 4.54 | Protein ratios | Myeloid | 3 | 3 | 14 | 28 | |
| 724 | GGACT levels | PROLV000880 | 4.54 | Protein levels | Lymphocyte | 3 | 2 | 9 | 28 | |
| 725 | DSG3/NECTIN4 ratio | PRORT000954 | 4.53 | Protein ratios | Lymphocyte | 35 | 0 | 15 | 27 | |
| 726 | IFNAR1 levels | PROLV001018 | 4.52 | Protein levels | Myeloid | 52 | 4 | 11 | 23 | |
| 727 | CNTNAP2/DPP6 ratio | PRORT000690 | 4.52 | Protein ratios | Neural / glial | 0 | 2 | 13 | 27 | |
| 728 | UROD levels | PROLV002143 | 4.52 | Protein levels | Lymphocyte | 2 | 2 | 9 | 33 | |
| 729 | CD27/ICAM3 ratio | PRORT000414 | 4.52 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 730 | EDAR/ITGB1BP2 ratio | PRORT000972 | 4.51 | Protein ratios | Myeloid | 49 | 5 | 17 | 20 | |
| 731 | CCL17/F2R ratio | PRORT000344 | 4.51 | Protein ratios | Myeloid | 16 | 4 | 12 | 35 | |
| 732 | CCL13 levels | PROLV000279 | 4.50 | Protein levels | Myeloid | 139 | 1 | 8 | 13 | |
| 733 | Oedema | MISCL000012 | 4.50 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 734 | CD58/ROR1 ratio | PRORT000478 | 4.49 | Protein ratios | Hepatocyte | 0 | 3 | 15 | 30 | |
| 735 | SHMT1 levels | PROLV001857 | 4.49 | Protein levels | Stromal / connective | 0 | 4 | 12 | 30 | |
| 736 | MIF levels | PROLV001313 | 4.48 | Protein levels | Lymphocyte | 4 | 1 | 5 | 28 | |
| 737 | Smoking dependency | PSYCH000047 | 4.47 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 738 | TNFRSF4 levels | PROLV002071 | 4.47 | Protein levels | Lymphocyte | 72 | 1 | 8 | 16 | |
| 739 | DCTN6 levels | PROLV000604 | 4.45 | Protein levels | Vascular | 0 | 4 | 13 | 31 | |
| 740 | Chronic viral hepatitis | IMMUN000056 | 4.44 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 741 | FOXO1/IRAK4 ratio | PRORT001172 | 4.42 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 29 | |
| 742 | CD5/CD6 ratio | PRORT000466 | 4.41 | Protein ratios | Myeloid | 22 | 4 | 11 | 17 | |
| 743 | CEP43/MPHOSPH8 ratio | PRORT000599 | 4.41 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 744 | ATP5IF1/METAP1D ratio | PRORT000160 | 4.40 | Protein ratios | Myeloid | 6 | 3 | 9 | 28 | |
| 745 | ITGB1/ITGB2 ratio | PRORT001376 | 4.40 | Protein ratios | Myeloid | 75 | 3 | 15 | 21 | |
| 746 | GPC5 levels | PROLV000920 | 4.40 | Protein levels | Myeloid | 71 | 2 | 9 | 20 | |
| 747 | BAP18 levels | PROLV000179 | 4.39 | Protein levels | Vascular | 44 | 4 | 13 | 39 | |
| 748 | CA2/CA3 ratio | PRORT000274 | 4.37 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 749 | AMOTL2 levels | PROLV000088 | 4.36 | Protein levels | Lymphocyte | 1 | 0 | 9 | 14 | |
| 750 | IMPACT levels | PROLV001085 | 4.36 | Protein levels | Muscle / cardiac | 1 | 5 | 11 | 38 | |
| 751 | TNFSF14 levels | PROLV002080 | 4.35 | Protein levels | Myeloid | 15 | 2 | 6 | 24 | |
| 752 | LAMA4/PDGFB ratio | PRORT001420 | 4.34 | Protein ratios | Neural / glial | 19 | 3 | 10 | 28 | |
| 753 | FUT8/PDGFA ratio | PRORT001187 | 4.34 | Protein ratios | Hepatocyte | 8 | 2 | 15 | 50 | |
| 754 | CD46/TIMP1 ratio | PRORT000461 | 4.32 | Protein ratios | Lymphocyte | 6 | 2 | 10 | 32 | |
| 755 | MED18/TBL1X ratio | PRORT001511 | 4.31 | Protein ratios | Myeloid | 35 | 3 | 11 | 22 | |
| 756 | BACH1/SNAP23 ratio | PRORT000198 | 4.30 | Protein ratios | Myeloid | 0 | 3 | 15 | 19 | |
| 757 | ICAM4 levels | PROLV001007 | 4.29 | Protein levels | Lymphocyte | 53 | 2 | 13 | 33 | |
| 758 | Nucleoside metabolites | METAB000061 | 4.29 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 759 | Spondyloarthritis | IMMUN000044 | 4.29 | Immunologic | Myeloid | 110 | 4 | 8 | 20 | |
| 760 | COMP/ICAM1 ratio | PRORT000710 | 4.29 | Protein ratios | Myeloid | 38 | 4 | 10 | 17 | |
| 761 | APP/EGF ratio | PRORT000124 | 4.28 | Protein ratios | Vascular | 6 | 5 | 17 | 39 | |
| 762 | Food-related dermatitis | DERMA000011 | 4.28 | Dermatologic | Lymphocyte | 0 | 0 | 9 | 19 | |
| 763 | EBAG9/TBCC ratio | PRORT000962 | 4.28 | Protein ratios | Muscle / cardiac | 5 | 3 | 16 | 46 | |
| 764 | CXCL5/EDAR ratio | PRORT000827 | 4.28 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 765 | Cancer, Urinary tract | MALIG000033 | 4.28 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 766 | CXCL8 levels | PROLV000586 | 4.27 | Protein levels | Myeloid | 39 | 3 | 11 | 20 | |
| 767 | OPLAH levels | PROLV001471 | 4.26 | Protein levels | Lymphocyte | 8 | 0 | 7 | 13 | |
| 768 | FOXO1/NUB1 ratio | PRORT001175 | 4.25 | Protein ratios | Myeloid | 0 | 2 | 13 | 20 | |
| 769 | IL12RB1 levels | PROLV001046 | 4.25 | Protein levels | Muscle / cardiac | 54 | 5 | 14 | 18 | |
| 770 | FCER1A levels | PROLV000776 | 4.23 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 771 | HGF/MMP9 ratio | PRORT001283 | 4.21 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 28 | |
| 772 | Wellbeing | PSYCH000056 | 4.21 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 773 | FOXO1/NFATC1 ratio | PRORT001174 | 4.21 | Protein ratios | Muscle / cardiac | 0 | 4 | 16 | 37 | |
| 774 | CCN1/DNAJB1 ratio | PRORT000361 | 4.19 | Protein ratios | Hepatocyte | 26 | 4 | 14 | 37 | |
| 775 | Latent factor, red cell | HEMAT000038 | 4.19 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 776 | CXCL5/PPIB ratio | PRORT000830 | 4.18 | Protein ratios | Platelet | 1 | 6 | 12 | 30 | |
| 777 | Viral wart | IMMUN000079 | 4.18 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 778 | BLVRB/HMBS ratio | PRORT000243 | 4.18 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 779 | Brain age gap | NIMAG000004 | 4.17 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 780 | MMP9/OLR1 ratio | PRORT001546 | 4.17 | Protein ratios | Myeloid | 15 | 3 | 7 | 16 | |
| 781 | IL22 levels | PROLV001066 | 4.16 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 782 | FXN/TRIAP1 ratio | PRORT001195 | 4.14 | Protein ratios | Myeloid | 1 | 2 | 6 | 11 | |
| 783 | AKT1S1/TDRKH ratio | PRORT000066 | 4.14 | Protein ratios | Stromal / connective | 0 | 3 | 9 | 28 | |
| 784 | EBAG9/TGFB1 ratio | PRORT000963 | 4.14 | Protein ratios | Myeloid | 11 | 4 | 18 | 48 | |
| 785 | RNASE3 levels | PROLV001738 | 4.13 | Protein levels | Myeloid | 39 | 4 | 15 | 28 | |
| 786 | Intervertebral disc disorder | MSKEL000076 | 4.13 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 787 | GIMAP7 levels | PROLV000887 | 4.12 | Protein levels | Lymphocyte | 26 | 2 | 10 | 41 | |
| 788 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 4.10 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 789 | CCL17/THPO ratio | PRORT000347 | 4.09 | Protein ratios | Myeloid | 11 | 4 | 10 | 37 | |
| 790 | CD300E/CXCL10 ratio | PRORT000430 | 4.08 | Protein ratios | Myeloid | 7 | 4 | 15 | 26 | |
| 791 | CDKN2D/TACC3 ratio | PRORT000580 | 4.07 | Protein ratios | Hematopoietic progenitor | 1 | 4 | 11 | 29 | |
| 792 | ADA levels | PROLV000023 | 4.07 | Protein levels | Myeloid | 17 | 5 | 18 | 32 | |
| 793 | Cutaneous fungal infection | IMMUN000058 | 4.06 | Immunologic | Myeloid | 28 | 1 | 9 | 13 | |
| 794 | Vertigo | AUDIO000021 | 4.06 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 795 | CD69/NFATC1 ratio | PRORT000493 | 4.05 | Protein ratios | Myeloid | 0 | 2 | 13 | 37 | |
| 796 | CEBPB/NADK ratio | PRORT000591 | 4.05 | Protein ratios | Myeloid | 1 | 1 | 6 | 15 | |
| 797 | IL7R levels | PROLV001081 | 4.05 | Protein levels | Hepatocyte | 78 | 3 | 10 | 27 | |
| 798 | STAMBP/WWP2 ratio | PRORT001817 | 4.05 | Protein ratios | Muscle / cardiac | 8 | 4 | 9 | 20 | |
| 799 | QPCT/RNASET2 ratio | PRORT001726 | 4.04 | Protein ratios | B / plasma cell | 68 | 5 | 12 | 31 | |
| 800 | FCGR2A/FCGR2B ratio | PRORT001124 | 4.01 | Protein ratios | Myeloid | 41 | 3 | 12 | 20 | |
| 801 | APP/FKBP1B ratio | PRORT000125 | 3.98 | Protein ratios | Myeloid | 0 | 4 | 15 | 21 | |
| 802 | ERBB2/GUSB ratio | PRORT001043 | 3.97 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 803 | CXCL17/LAMP3 ratio | PRORT000823 | 3.97 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 804 | FCRL2/SEMA7A ratio | PRORT001131 | 3.97 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 805 | CLEC6A levels | PROLV000456 | 3.96 | Protein levels | Myeloid | 53 | 3 | 9 | 17 | |
| 806 | CD200R1/CLEC4G ratio | PRORT000394 | 3.96 | Protein ratios | Myeloid | 11 | 4 | 15 | 25 | |
| 807 | CDC37/SNAP29 ratio | PRORT000541 | 3.95 | Protein ratios | Myeloid | 18 | 4 | 13 | 31 | |
| 808 | MED18/SMAD1 ratio | PRORT001509 | 3.95 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 809 | POF1B levels | PROLV001597 | 3.94 | Protein levels | Myeloid | 7 | 3 | 17 | 20 | |
| 810 | VCAM1 levels | PROLV002155 | 3.93 | Protein levels | Myeloid | 128 | 2 | 6 | 10 | |
| 811 | PDGFA/USP8 ratio | PRORT001638 | 3.92 | Protein ratios | Myeloid | 3 | 4 | 16 | 26 | |
| 812 | Gut microbial abundance, Rubneribacter | GASTR000035 | 3.92 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 813 | PAPL levels | PROLV001494 | 3.91 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 814 | NUBP1 levels | PROLV001450 | 3.91 | Protein levels | B / plasma cell | 26 | 1 | 8 | 16 | |
| 815 | EDAR/TXNDC5 ratio | PRORT000984 | 3.90 | Protein ratios | Myeloid | 50 | 2 | 7 | 16 | |
| 816 | CIAPIN1/SNX9 ratio | PRORT000617 | 3.90 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 817 | TIA1/USP8 ratio | PRORT001837 | 3.90 | Protein ratios | Hepatocyte | 12 | 3 | 11 | 37 | |
| 818 | CASP3/LYN ratio | PRORT000314 | 3.89 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 819 | COVID-19 | IMMUN000054 | 3.88 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 820 | OGA levels | PROLV001463 | 3.88 | Protein levels | Lymphocyte | 7 | 5 | 11 | 29 | |
| 821 | Urticaria | IMMUN000007 | 3.88 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 822 | CD40 levels | PROLV000340 | 3.87 | Protein levels | Platelet | 9 | 1 | 2 | 4 | |
| 823 | DNAJB14 levels | PROLV000631 | 3.87 | Protein levels | Muscle / cardiac | 12 | 2 | 3 | 16 | |
| 824 | SEMA4D/TREML2 ratio | PRORT001771 | 3.85 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 6 | 24 | |
| 825 | Methionine metabolites | METAB000010 | 3.84 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 826 | VNN2 levels | PROLV002165 | 3.83 | Protein levels | Myeloid | 72 | 2 | 11 | 14 | |
| 827 | EBV EA-D antibody | IMMUN000060 | 3.82 | Immunologic | Muscle / cardiac | 8 | 1 | 5 | 13 | |
| 828 | ACRBP levels | PROLV000016 | 3.81 | Protein levels | Lymphocyte | 3 | 2 | 7 | 20 | |
| 829 | SDK2 levels | PROLV001800 | 3.79 | Protein levels | Myeloid | 29 | 3 | 14 | 24 | |
| 830 | CCL5/RARRES2 ratio | PRORT000357 | 3.77 | Protein ratios | Myeloid | 12 | 1 | 3 | 15 | |
| 831 | LY6D/WFDC12 ratio | PRORT001470 | 3.77 | Protein ratios | Myeloid | 14 | 2 | 17 | 20 | |
| 832 | SEC31A levels | PROLV001801 | 3.75 | Protein levels | Stromal / connective | 9 | 2 | 6 | 23 | |
| 833 | Middle ear and mastoid disorder | AUDIO000016 | 3.75 | Auditory | B / plasma cell | 51 | 4 | 14 | 30 | |
| 834 | DAG1/HBEGF ratio | PRORT000848 | 3.75 | Protein ratios | Myeloid | 61 | 2 | 10 | 15 | |
| 835 | Vestibular disorder | AUDIO000022 | 3.74 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 836 | NADK levels | PROLV001370 | 3.74 | Protein levels | Myeloid | 42 | 2 | 7 | 16 | |
| 837 | DCTN6/TDRKH ratio | PRORT000875 | 3.74 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 31 | |
| 838 | SERPINE1/VASH1 ratio | PRORT001780 | 3.74 | Protein ratios | Myeloid | 10 | 3 | 11 | 23 | |
| 839 | CCL18/RARRES2 ratio | PRORT000348 | 3.73 | Protein ratios | Myeloid | 8 | 2 | 10 | 15 | |
| 840 | ANGPT1/CCN2 ratio | PRORT000092 | 3.73 | Protein ratios | Myeloid | 5 | 3 | 12 | 14 | |
| 841 | DCTN1/FXN ratio | PRORT000872 | 3.72 | Protein ratios | Hepatocyte | 0 | 4 | 15 | 34 | |
| 842 | ALCAM/ICAM3 ratio | PRORT000071 | 3.71 | Protein ratios | Hepatocyte | 12 | 2 | 6 | 14 | |
| 843 | Birth complication | REPRO000036 | 3.70 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 844 | DNAJC9 levels | PROLV000636 | 3.70 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 845 | MAD1L1 levels | PROLV001257 | 3.69 | Protein levels | Myeloid | 6 | 5 | 12 | 26 | |
| 846 | ITGB1BP2/MITD1 ratio | PRORT001385 | 3.69 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 847 | TNF levels | PROLV002053 | 3.67 | Protein levels | Lymphocyte | 30 | 2 | 10 | 20 | |
| 848 | TAX1BP3 levels | PROLV001995 | 3.67 | Protein levels | Myeloid | 0 | 2 | 5 | 6 | |
| 849 | TNFRSF8/TNFRSF9 ratio | PRORT001855 | 3.67 | Protein ratios | Myeloid | 3 | 4 | 12 | 23 | |
| 850 | Neoplasm, uncertain behaviour | MALIG000035 | 3.67 | Malignancy | Lymphocyte | 1 | 2 | 9 | 26 | |
| 851 | ELAC1 levels | PROLV000699 | 3.67 | Protein levels | Lymphocyte | 2 | 3 | 8 | 33 | |
| 852 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 3.67 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 853 | FUT3 or FUT5 levels | PROLV000838 | 3.66 | Protein levels | Hepatocyte | 85 | 2 | 17 | 39 | |
| 854 | Employment status | SOCIO000005 | 3.66 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 855 | FTCD levels | PROLV000832 | 3.66 | Protein levels | Hepatocyte | 62 | 1 | 8 | 22 | |
| 856 | EDAR/F11R ratio | PRORT000968 | 3.66 | Protein ratios | Myeloid | 23 | 3 | 7 | 20 | |
| 857 | ICAM3/NOTCH1 ratio | PRORT001327 | 3.64 | Protein ratios | Hepatocyte | 22 | 2 | 9 | 23 | |
| 858 | C1R levels | PROLV000227 | 3.64 | Protein levels | Hepatocyte | 0 | 4 | 15 | 29 | |
| 859 | Iron metabolism disorder | METBL000019 | 3.63 | Metabolic | Myeloid | 59 | 1 | 5 | 24 | |
| 860 | Hospital admission | MISCL000022 | 3.62 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 861 | CD40LG/EDAR ratio | PRORT000448 | 3.62 | Protein ratios | Myeloid | 8 | 2 | 10 | 16 | |
| 862 | CD274 levels | PROLV000325 | 3.62 | Protein levels | Muscle / cardiac | 5 | 2 | 5 | 10 | |
| 863 | CLEC4G/KEL ratio | PRORT000659 | 3.61 | Protein ratios | Myeloid | 43 | 2 | 12 | 33 | |
| 864 | CD74/DLL1 ratio | PRORT000502 | 3.59 | Protein ratios | Vascular | 48 | 2 | 13 | 37 | |
| 865 | INPP5J levels | PROLV001090 | 3.58 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 866 | PLXNA4/USP8 ratio | PRORT001688 | 3.57 | Protein ratios | B / plasma cell | 5 | 4 | 8 | 32 | |
| 867 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 3.57 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 868 | ERBB4/F3 ratio | PRORT001046 | 3.57 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 28 | |
| 869 | CABP2 levels | PROLV000249 | 3.57 | Protein levels | B / plasma cell | 21 | 2 | 4 | 10 | |
| 870 | LIFR levels | PROLV001210 | 3.55 | Protein levels | Vascular | 75 | 4 | 12 | 46 | |
| 871 | APBB1IP levels | PROLV000112 | 3.55 | Protein levels | Myeloid | 38 | 4 | 17 | 27 | |
| 872 | CLEC4G/NELL2 ratio | PRORT000662 | 3.55 | Protein ratios | Myeloid | 35 | 5 | 16 | 39 | |
| 873 | GBP4 levels | PROLV000862 | 3.54 | Protein levels | Neural / glial | 4 | 3 | 11 | 25 | |
| 874 | PLA2G15/PRCP ratio | PRORT001670 | 3.54 | Protein ratios | Myeloid | 44 | 3 | 11 | 21 | |
| 875 | SIAE levels | PROLV001858 | 3.54 | Protein levels | Lymphocyte | 17 | 3 | 11 | 36 | |
| 876 | PDGFRB levels | PROLV001526 | 3.54 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 877 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 3.52 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 878 | CTSF/NAAA ratio | PRORT000801 | 3.51 | Protein ratios | Hepatocyte | 46 | 3 | 13 | 23 | |
| 879 | GET3 levels | PROLV000873 | 3.51 | Protein levels | B / plasma cell | 3 | 2 | 3 | 21 | |
| 880 | HIP1R levels | PROLV000970 | 3.50 | Protein levels | Myeloid | 1 | 2 | 12 | 23 | |
| 881 | HBEGF/SDC4 ratio | PRORT001271 | 3.50 | Protein ratios | Myeloid | 56 | 2 | 9 | 18 | |
| 882 | FCRLB levels | PROLV000788 | 3.48 | Protein levels | B / plasma cell | 86 | 3 | 8 | 21 | |
| 883 | GPI levels | PROLV000923 | 3.48 | Protein levels | Myeloid | 8 | 1 | 1 | 8 | |
| 884 | GZMA/IL12A_IL12B ratio | PRORT001259 | 3.48 | Protein ratios | B / plasma cell | 51 | 3 | 7 | 8 | |
| 885 | MRPL33 levels | PROLV001339 | 3.47 | Protein levels | Hepatocyte | 21 | 3 | 13 | 11 | |
| 886 | Medication use | MISCL000037 | 3.45 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 887 | CXCL11/ITGB1BP2 ratio | PRORT000818 | 3.44 | Protein ratios | Muscle / cardiac | 1 | 3 | 8 | 15 | |
| 888 | TLR4 levels | PROLV002044 | 3.44 | Protein levels | Lymphocyte | 0 | 1 | 6 | 23 | |
| 889 | CCL22/PDGFB ratio | PRORT000351 | 3.44 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 890 | FHIT/PARK7 ratio | PRORT001146 | 3.44 | Protein ratios | Myeloid | 3 | 4 | 12 | 20 | |
| 891 | CCL8 levels | PROLV000300 | 3.43 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 892 | ITGAM/ITGAV ratio | PRORT001375 | 3.43 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 893 | EBAG9/HBEGF ratio | PRORT000959 | 3.42 | Protein ratios | Myeloid | 37 | 3 | 14 | 15 | |
| 894 | Cancer, Liver | MALIG000018 | 3.42 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 895 | Diabetes, type 2, autoimmune subtype | IMMUN000013 | 3.42 | Immunologic | Myeloid | — | 1 | 7 | 29 | |
| 896 | PSIP1 levels | PROLV001657 | 3.41 | Protein levels | Muscle / cardiac | 10 | 2 | 10 | 35 | |
| 897 | CCL17/CCL22 ratio | PRORT000342 | 3.41 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 31 | |
| 898 | MPHOSPH8/USP8 ratio | PRORT001555 | 3.40 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 899 | TNFRSF1A/TNFRSF1B ratio | PRORT001852 | 3.39 | Protein ratios | Myeloid | 44 | 3 | 12 | 20 | |
| 900 | Bone and cartilage disorder | MSKEL000006 | 3.39 | Musculoskeletal | Neural / glial | 1 | 0 | 0 | 4 | |
| 901 | CXCL11/VTA1 ratio | PRORT000820 | 3.39 | Protein ratios | Hepatocyte | 5 | 3 | 12 | 26 | |
| 902 | F2R levels | PROLV000745 | 3.39 | Protein levels | Lymphocyte | 23 | 2 | 5 | 21 | |
| 903 | FYB1/MESD ratio | PRORT001197 | 3.38 | Protein ratios | Myeloid | 0 | 5 | 13 | 26 | |
| 904 | Pain, neck | MSKEL000040 | 3.37 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 905 | LTBR/TNFRSF14 ratio | PRORT001467 | 3.37 | Protein ratios | Stromal / connective | 0 | 4 | 11 | 23 | |
| 906 | PDGFRA levels | PROLV001525 | 3.37 | Protein levels | Hepatocyte | 55 | 2 | 4 | 14 | |
| 907 | KHK levels | PROLV001135 | 3.37 | Protein levels | Hepatocyte | 45 | 3 | 16 | 39 | |
| 908 | Infertility | REPRO000010 | 3.37 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 909 | Endometriosis | REPRO000005 | 3.36 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 910 | STK24/TDRKH ratio | PRORT001820 | 3.36 | Protein ratios | Myeloid | 0 | 4 | 15 | 39 | |
| 911 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 3.36 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 912 | ABHD14B/SPARC ratio | PRORT000007 | 3.36 | Protein ratios | Myeloid | 1 | 3 | 8 | 20 | |
| 913 | MED18/TACC3 ratio | PRORT001510 | 3.35 | Protein ratios | Lymphocyte | 0 | 4 | 8 | 24 | |
| 914 | Ceramides | LIPID000065 | 3.34 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 915 | F11R/GP1BA ratio | PRORT001071 | 3.33 | Protein ratios | Myeloid | 9 | 3 | 13 | 17 | |
| 916 | EDAR/IRAK4 ratio | PRORT000971 | 3.32 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 917 | DBI/EDAR ratio | PRORT000861 | 3.32 | Protein ratios | Myeloid | 37 | 3 | 6 | 16 | |
| 918 | AXIN1/SRPK2 ratio | PRORT000177 | 3.31 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 38 | |
| 919 | MINPP1 levels | PROLV001317 | 3.31 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 920 | KAZN levels | PROLV001129 | 3.30 | Protein levels | Stromal / connective | 3 | 2 | 6 | 26 | |
| 921 | OLR1/OSM ratio | PRORT001612 | 3.29 | Protein ratios | Myeloid | 13 | 2 | 8 | 20 | |
| 922 | Financial satisfaction | SOCIO000024 | 3.29 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 923 | DOK2/PDLIM7 ratio | PRORT000940 | 3.29 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 924 | AXL/IL18BP ratio | PRORT000180 | 3.28 | Protein ratios | Neural / glial | 26 | 2 | 10 | 15 | |
| 925 | Enthesopathy | MSKEL000061 | 3.28 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 926 | S100A11 levels | PROLV001766 | 3.27 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 927 | HEXIM1/TBL1X ratio | PRORT001280 | 3.27 | Protein ratios | Myeloid | 4 | 3 | 12 | 30 | |
| 928 | Cutaneous cysts and sinuses | DERMA000002 | 3.26 | Dermatologic | Cutaneous epithelium | 30 | 0 | 13 | 20 | |
| 929 | Phosphatidylserines | LIPID000062 | 3.26 | Lipids | B / plasma cell | 0 | 0 | 5 | 17 | |
| 930 | CD46/SELP ratio | PRORT000458 | 3.24 | Protein ratios | Granulosa cell | 2 | 3 | 7 | 16 | |
| 931 | EDAR/SERPINB1 ratio | PRORT000977 | 3.22 | Protein ratios | Myeloid | 29 | 2 | 8 | 14 | |
| 932 | PTS levels | PROLV001684 | 3.21 | Protein levels | Hepatocyte | 20 | 1 | 8 | 19 | |
| 933 | SERPINE1/SMAD1 ratio | PRORT001777 | 3.21 | Protein ratios | Myeloid | 4 | 4 | 14 | 28 | |
| 934 | DKK1/ZBTB16 ratio | PRORT000907 | 3.21 | Protein ratios | Myeloid | 4 | 3 | 11 | 13 | |
| 935 | Heme malignancy, Leukaemia | MALIG000042 | 3.20 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 936 | ADH4/KYNU ratio | PRORT000041 | 3.19 | Protein ratios | Hepatocyte | 41 | 4 | 16 | 28 | |
| 937 | CD74/JAM2 ratio | PRORT000504 | 3.18 | Protein ratios | Myeloid | 51 | 4 | 10 | 17 | |
| 938 | MSTN/RGMA ratio | PRORT001564 | 3.18 | Protein ratios | Muscle / cardiac | 12 | 2 | 12 | 27 | |
| 939 | CDH6 levels | PROLV000377 | 3.17 | Protein levels | Hepatocyte | 17 | 3 | 12 | 29 | |
| 940 | ING1 levels | PROLV001086 | 3.17 | Protein levels | Vascular | 0 | 3 | 8 | 26 | |
| 941 | Gastric ulcer | GASTR000048 | 3.15 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 942 | CALCOCO1/PDLIM7 ratio | PRORT000300 | 3.15 | Protein ratios | Myeloid | 1 | 3 | 11 | 27 | |
| 943 | ADGRE5/ITGB2 ratio | PRORT000031 | 3.15 | Protein ratios | Myeloid | 75 | 4 | 11 | 15 | |
| 944 | Smoking behaviour | PSYCH000046 | 3.13 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 945 | BACH1/CD2AP ratio | PRORT000191 | 3.13 | Protein ratios | Hepatocyte | 17 | 2 | 14 | 35 | |
| 946 | Frailty, metabolic problems | METBL000011 | 3.12 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 947 | CCL17/GRK5 ratio | PRORT000345 | 3.12 | Protein ratios | Myeloid | 18 | 4 | 8 | 21 | |
| 948 | CLU levels | PROLV000467 | 3.12 | Protein levels | Granulosa cell | 75 | 5 | 15 | 24 | |
| 949 | CANT1/ROR1 ratio | PRORT000309 | 3.12 | Protein ratios | Hepatocyte | 3 | 1 | 9 | 25 | |
| 950 | SDC4 levels | PROLV001797 | 3.11 | Protein levels | Hematopoietic progenitor | 103 | 3 | 7 | 20 | |
| 951 | CCN2/HBEGF ratio | PRORT000365 | 3.10 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 952 | ELOA levels | PROLV000701 | 3.10 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 953 | QPCT levels | PROLV001693 | 3.09 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 954 | CCL21 levels | PROLV000288 | 3.09 | Protein levels | Lymphocyte | 35 | 1 | 4 | 11 | |
| 955 | CCL28 levels | PROLV000295 | 3.09 | Protein levels | Myeloid | 61 | 2 | 8 | 17 | |
| 956 | Respiratory symptom | RESPI000032 | 3.09 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 957 | IMMT levels | PROLV001083 | 3.08 | Protein levels | Vascular | 0 | 0 | 6 | 20 | |
| 958 | NID2 levels | PROLV001405 | 3.08 | Protein levels | Myeloid | 59 | 2 | 7 | 15 | |
| 959 | CLEC4G/KDR ratio | PRORT000658 | 3.08 | Protein ratios | Myeloid | 37 | 4 | 14 | 22 | |
| 960 | Study participation | BEHAV000004 | 3.08 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 961 | Gastrointestinal polyps | GASTR000005 | 3.07 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 962 | FCRL1/TNFRSF13C ratio | PRORT001127 | 3.07 | Protein ratios | B / plasma cell | 39 | 3 | 7 | 10 | |
| 963 | ITGB1BP2/WASF1 ratio | PRORT001391 | 3.06 | Protein ratios | Myeloid | 0 | 3 | 9 | 24 | |
| 964 | Viral haemorrhagic fever | IMMUN000075 | 3.06 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 965 | CD22/SEMA7A ratio | PRORT000403 | 3.05 | Protein ratios | B / plasma cell | 54 | 3 | 10 | 26 | |
| 966 | IL22RA2 levels | PROLV001067 | 3.05 | Protein levels | Myeloid | 0 | 2 | 13 | 12 | |
| 967 | CRADD/EREG ratio | PRORT000744 | 3.05 | Protein ratios | Myeloid | 1 | 3 | 9 | 17 | |
| 968 | IL3RA levels | PROLV001074 | 3.05 | Protein levels | Granulosa cell | 51 | 1 | 10 | 25 | |
| 969 | RGMB/TNFRSF21 ratio | PRORT001739 | 3.04 | Protein ratios | Myeloid | 17 | 3 | 12 | 30 | |
| 970 | DAG1/DKK1 ratio | PRORT000845 | 3.04 | Protein ratios | Myeloid | 32 | 2 | 9 | 17 | |
| 971 | CCNE1 levels | PROLV000306 | 3.03 | Protein levels | B / plasma cell | 8 | 0 | 6 | 17 | |
| 972 | Diabetes, type 1 with complication | IMMUN000011 | 3.03 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 973 | NECTIN2/NPDC1 ratio | PRORT001577 | 3.02 | Protein ratios | Vascular | 16 | 2 | 13 | 18 | |
| 974 | Benign neoplasm, Uterus | MALIG000008 | 3.01 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 975 | CCN2/EDAR ratio | PRORT000363 | 3.01 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 10 | 14 | |
| 976 | TGFBR2/THBD ratio | PRORT001833 | 3.01 | Protein ratios | Vascular | 24 | 1 | 5 | 23 | |
| 977 | CTSZ/HSPG2 ratio | PRORT000804 | 3.00 | Protein ratios | Hepatocyte | 35 | 5 | 12 | 20 | |
| 978 | Cancer, Thyroid | MALIG000032 | 2.99 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 979 | TIMP3 levels | PROLV002039 | 2.99 | Protein levels | Myeloid | 80 | 2 | 11 | 24 | |
| 980 | LPCAT2 levels | PROLV001221 | 2.99 | Protein levels | Hepatocyte | 0 | 1 | 4 | 18 | |
| 981 | Household composition | SOCIO000010 | 2.98 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 982 | FOXO1/MAP4K5 ratio | PRORT001173 | 2.98 | Protein ratios | Lymphocyte | 0 | 3 | 12 | 41 | |
| 983 | SH3BP1 levels | PROLV001853 | 2.97 | Protein levels | Myeloid | 33 | 1 | 7 | 6 | |
| 984 | Fatty acids ratio | LIPID000031 | 2.97 | Lipids | Hepatocyte | 426 | 2 | 8 | 18 | |
| 985 | Tryptophan metabolites | METAB000015 | 2.96 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 986 | FYB1/PDGFB ratio | PRORT001198 | 2.95 | Protein ratios | Myeloid | 10 | 3 | 12 | 20 | |
| 987 | BCR/GOPC ratio | PRORT000225 | 2.95 | Protein ratios | Hepatocyte | 4 | 3 | 10 | 33 | |
| 988 | MCTS1 levels | PROLV001287 | 2.95 | Protein levels | Myeloid | 59 | 3 | 10 | 14 | |
| 989 | ANXA1 levels | PROLV000104 | 2.94 | Protein levels | Muscle / cardiac | 2 | 2 | 5 | 18 | |
| 990 | Benign neoplasm, Ocular | MALIG000005 | 2.94 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 991 | AXL/VCAM1 ratio | PRORT000183 | 2.94 | Protein ratios | Myeloid | 85 | 4 | 15 | 37 | |
| 992 | CD84/DKK1 ratio | PRORT000522 | 2.94 | Protein ratios | Myeloid | 20 | 3 | 7 | 22 | |
| 993 | Amino sugar metabolites | METAB000034 | 2.94 | Metabolites | Lymphocyte | 0 | 1 | 5 | 20 | |
| 994 | LAMP3/PRSS8 ratio | PRORT001421 | 2.93 | Protein ratios | Lymphocyte | 5 | 3 | 8 | 30 | |
| 995 | WNT9A levels | PROLV002194 | 2.93 | Protein levels | Muscle / cardiac | 20 | 2 | 6 | 20 | |
| 996 | F11R levels | PROLV000742 | 2.93 | Protein levels | Lymphocyte | 31 | 2 | 10 | 21 | |
| 997 | SNAP23/ZBTB16 ratio | PRORT001796 | 2.92 | Protein ratios | Lymphocyte | 9 | 3 | 8 | 23 | |
| 998 | LBR/MAD1L1 ratio | PRORT001438 | 2.92 | Protein ratios | Myeloid | 0 | 3 | 10 | 24 | |
| 999 | FLT4/KDR ratio | PRORT001167 | 2.92 | Protein ratios | Vascular | 28 | 1 | 7 | 21 | |
| 1000 | Lysine metabolites | METAB000009 | 2.92 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 |